Podcasts about Kushner

TODAY: Nintendo fans EXPLODE at the video game company's disrespect: this time advertising a game where you play basketball in a WHEELCHAIR. When will this century of humiliation for gamers end? ALSO: Republicans and Democrats both have rugs pulled out from under them as Trump's plants in the FBI Kash Patel and Dan Bongino inform their base that Epstein did in fact kill himself and there's nothing strange about it. Meanwhile, filibusterin' fool Cory Booker becomes the only Democrat voting to confirm convicted blackmailer Charles Kushner (Jared's dad) as ambassador to France, and Democrats find out just how close the New Jersey senator is to the Kushner family. Is there any zionist liberal who can save us? Get a bonus episode every week by signing up at http://patreon.com/miniondeathcult for only $5/month   

In this episode, Dr. Jaime Almandoz, Associate Professor of Medicine at UT Southwestern, is joined by Dr. Robert F. Kushner, Professor of Medicine at Northwestern University and a leading authority in obesity medicine, to discuss the recent Lancet Diabetes & Endocrinology Commission report, “Definition and Diagnostic Criteria of Clinical Obesity.” The report introduces a new framework for defining clinical and preclinical obesity, aiming to move beyond the limitations of BMI. Dr. Kushner shares insights into the Commission's global consensus process and how the updated definitions can transform care, reduce weight stigma, and support more targeted treatment. Don't miss this timely conversation on the evolving future of obesity diagnosis and management.

00:03:50 - 00:18:12Trump's $175 billion Golden Dome missile defense system aims to use space-based interceptors to counter advanced missiles, but China warns it risks militarizing space and sparking an arms race. Congress estimates costs at $500 billion over 20 years. Russia's nuclear-powered Burevestnik missile, with unlimited range, could render it obsolete, raising concerns about budget overruns and SpaceX's involvement. 00:18:36 - 00:26:10Neocons push for war with Iran, demanding its nuclear program's dismantlement, while MAGA influencers like Bannon and Greene favor diplomacy. This reflects public exhaustion with Middle East wars, opposing defense contractors' agendas, with the host noting a hopeful shift against escalation. 00:31:12 - 00:38:12The Pentagon, citing unverified Chinese “super soldier” claims, proposes genetic experiments on U.S. troops using CRISPR and mRNA, alongside biosurveillance. Ethical concerns arise over human experimentation and CIA ties, with deregulation favoring biotech firms, risking taxpayer funds and safety. 00:44:45 - 00:53:36Trump grants asylum to 54 Afrikaner South Africans facing violence and land confiscation, confronting Ramaphosa with evidence of “white genocide.” The host supports this, criticizing media deflections and narrow refugee definitions, emphasizing the severe persecution Afrikaners endure. 01:17:37 - 01:36:07The FDA now requires trials for COVID-19 vaccines for healthy people aged 6 months to 64, but approved high-risk group vaccines without data, rushed by Trump's “warp speed.” A Senate report reveals Biden officials hid myocarditis risks in young men, delaying warnings despite early signals, driven by corporate interests. Low vaccine uptake (13% kids, 23% adults) and rising heart issues highlight the cover-up. 01:36:07 - 01:40:50Medpage Today confirms RFK Jr.'s claim that the MMR mumps vaccine is ineffective, admitting Merck's fraudulent data, but dismisses him as a lawyer. Failed lawsuits left untested, harmful vaccines on the market, with one-third of trial kids facing health issues, exposing systemic vaccine regulation flaws. 01:48:10 - 02:01:35A bill strips states' AI regulation rights for 10 years, a Trump-backed federal power grab seen as unconstitutional. States urged to block AI infrastructure. Vermont pauses its EV mandate, citing weak tech and infrastructure, resisting California's 2035 EV push, which could set a national standard. 02:04:03 - 02:08:48Rep. Luna's bill seeks to repeal the Patriot Act, blamed for post-9/11 surveillance and rights violations. The host sees 9/11 as a pretext for wars and a police state, urging the act's end to curb intelligence agency abuses and restore privacy. 02:10:21 - 02:34:23Cecile Richards, dead at 67 from brain cancer, is condemned for leading 3.5 million abortions at Planned Parenthood and alleged fetal part sales. Her unrepentant stance, Freedom from Religion awards, and Biden's Medal of Freedom are criticized as anti-God. Kushner's 2017 funding offer was rejected. Abortion's 2024 toll (45.1 million, 42% of deaths) and 60% of African American deaths are called “black genocide.” GOP's funding via CARES Act ($80 million) and MAGA's defense of Trump's vaccines are slammed. 02:37:05 - 02:49:03Brown Foods' “Unreal Milk” and Israeli lab-grown dairy, like Wilk, claim to cut emissions by 82%, backed by Gates and USDA despite no farming. Biomilq targets infants, tied to C40's no-dairy push. Called “tumor milk,” it's criticized as an anti-agriculture, climate-driven scam with lax FDA oversight. 02:50:39 - 03:00:36Trump's “Gold Card” visa, costing $5 million, claims 250,000 applicants to raise $1 trillion, but only 277,000 global millionaires qualify. Offering tax-free foreign income and no country caps, it's decried as a corrupt deal for Trump's allies, bypassing vetting and America-first values.Follow the show on Kick and watch live every weekday 9:00am EST – 12:00pm EST https://kick.com/davidknightshow Money should have intrinsic value AND transactional privacy: Go to https://davidknight.gold/ for great deals on physical gold/silver For 10% off Gerald Celente's prescient Trends Journal, go to https://trendsjournal.com/ and enter the code KNIGHT Find out more about the show and where you can watch it at TheDavidKnightShow.comIf you would like to support the show and our family please consider subscribing monthly here: SubscribeStar https://www.subscribestar.com/the-david-knight-showOr you can send a donation throughMail: David Knight POB 994 Kodak, TN 37764Zelle: @DavidKnightShow@protonmail.comCash App at: $davidknightshowBTC to: bc1qkuec29hkuye4xse9unh7nptvu3y9qmv24vanh7Become a supporter of this podcast: https://www.spreaker.com/podcast/the-david-knight-show--2653468/support.

00:03:50 - 00:18:12Trump's $175 billion Golden Dome missile defense system aims to use space-based interceptors to counter advanced missiles, but China warns it risks militarizing space and sparking an arms race. Congress estimates costs at $500 billion over 20 years. Russia's nuclear-powered Burevestnik missile, with unlimited range, could render it obsolete, raising concerns about budget overruns and SpaceX's involvement. 00:18:36 - 00:26:10Neocons push for war with Iran, demanding its nuclear program's dismantlement, while MAGA influencers like Bannon and Greene favor diplomacy. This reflects public exhaustion with Middle East wars, opposing defense contractors' agendas, with the host noting a hopeful shift against escalation. 00:31:12 - 00:38:12The Pentagon, citing unverified Chinese “super soldier” claims, proposes genetic experiments on U.S. troops using CRISPR and mRNA, alongside biosurveillance. Ethical concerns arise over human experimentation and CIA ties, with deregulation favoring biotech firms, risking taxpayer funds and safety. 00:44:45 - 00:53:36Trump grants asylum to 54 Afrikaner South Africans facing violence and land confiscation, confronting Ramaphosa with evidence of “white genocide.” The host supports this, criticizing media deflections and narrow refugee definitions, emphasizing the severe persecution Afrikaners endure. 01:17:37 - 01:36:07The FDA now requires trials for COVID-19 vaccines for healthy people aged 6 months to 64, but approved high-risk group vaccines without data, rushed by Trump's “warp speed.” A Senate report reveals Biden officials hid myocarditis risks in young men, delaying warnings despite early signals, driven by corporate interests. Low vaccine uptake (13% kids, 23% adults) and rising heart issues highlight the cover-up. 01:36:07 - 01:40:50Medpage Today confirms RFK Jr.'s claim that the MMR mumps vaccine is ineffective, admitting Merck's fraudulent data, but dismisses him as a lawyer. Failed lawsuits left untested, harmful vaccines on the market, with one-third of trial kids facing health issues, exposing systemic vaccine regulation flaws. 01:48:10 - 02:01:35A bill strips states' AI regulation rights for 10 years, a Trump-backed federal power grab seen as unconstitutional. States urged to block AI infrastructure. Vermont pauses its EV mandate, citing weak tech and infrastructure, resisting California's 2035 EV push, which could set a national standard. 02:04:03 - 02:08:48Rep. Luna's bill seeks to repeal the Patriot Act, blamed for post-9/11 surveillance and rights violations. The host sees 9/11 as a pretext for wars and a police state, urging the act's end to curb intelligence agency abuses and restore privacy. 02:10:21 - 02:34:23Cecile Richards, dead at 67 from brain cancer, is condemned for leading 3.5 million abortions at Planned Parenthood and alleged fetal part sales. Her unrepentant stance, Freedom from Religion awards, and Biden's Medal of Freedom are criticized as anti-God. Kushner's 2017 funding offer was rejected. Abortion's 2024 toll (45.1 million, 42% of deaths) and 60% of African American deaths are called “black genocide.” GOP's funding via CARES Act ($80 million) and MAGA's defense of Trump's vaccines are slammed. 02:37:05 - 02:49:03Brown Foods' “Unreal Milk” and Israeli lab-grown dairy, like Wilk, claim to cut emissions by 82%, backed by Gates and USDA despite no farming. Biomilq targets infants, tied to C40's no-dairy push. Called “tumor milk,” it's criticized as an anti-agriculture, climate-driven scam with lax FDA oversight. 02:50:39 - 03:00:36Trump's “Gold Card” visa, costing $5 million, claims 250,000 applicants to raise $1 trillion, but only 277,000 global millionaires qualify. Offering tax-free foreign income and no country caps, it's decried as a corrupt deal for Trump's allies, bypassing vetting and America-first values.Follow the show on Kick and watch live every weekday 9:00am EST – 12:00pm EST https://kick.com/davidknightshow Money should have intrinsic value AND transactional privacy: Go to https://davidknight.gold/ for great deals on physical gold/silver For 10% off Gerald Celente's prescient Trends Journal, go to https://trendsjournal.com/ and enter the code KNIGHT Find out more about the show and where you can watch it at TheDavidKnightShow.comIf you would like to support the show and our family please consider subscribing monthly here: SubscribeStar https://www.subscribestar.com/the-david-knight-showOr you can send a donation throughMail: David Knight POB 994 Kodak, TN 37764Zelle: @DavidKnightShow@protonmail.comCash App at: $davidknightshowBTC to: bc1qkuec29hkuye4xse9unh7nptvu3y9qmv24vanh7Become a supporter of this podcast: https://www.spreaker.com/podcast/the-real-david-knight-show--5282736/support.

Wednesday, May 21st, 2025Today, Trump prosecutors have dropped the charges against Newark Mayor Ras Baraka, but have arrested and charged Congresswoman LaMonica McIver; Trump's Gestapo Czar doesn't know what habeas corpus is; the Supreme Court allows Maine Rep Libby to vote again despite her censure by the legislature for transphobic comments; USAID cuts leaves food for millions rotting in storage; a federal appeals court leaves in place an order requiring the Trump administration to return Daniel Lozano-Camargo to the US after having sent him there in violation of a legal settlement; Republicans in Congress have decided to phase out Biden's clean energy tax credits to make more room for billionaire tax cuts; the Senate has confirmed convicted felon Charles Kushner to be the ambassador of France; and Allison and Dana deliver your Good News.Thank You, Helix27% Off Sitewide plus Free Bedding Bundle with any Luxe or Elite Mattress Order, when you go to HelixSleep.com/dailybeansMSW Media, Blue Wave California Victory Fund | ActBlueStories:The Head of Trump's Gestapo Thinks Habeas Corpus is a Presidential Power | muellershewrote.comRep. LaMonica McIver charged after skirmish at ICE facility; Newark Mayor Baraka's charges dropped | ABC7 New YorkExclusive: US aid cuts leave food for millions mouldering in storage | ReutersTrump admin must seek return of wrongly deported man to El Salvador, appeals court rules | POLITICOUS Senate confirms Trump nominee Kushner to be ambassador to France | ReutersRepublicans tweak megabill's SNAP, Medicaid provisions - Live Updates | POLITICOA Jan. 6 rioter tried to recoup $63K he made filming the mob. A judge said no. | POLITICOGood Trouble: Your good trouble today is to contact the Attorney General of New Jersey, Matt Platkin, and have him look into code 3.12 Malicious Prosecution (Prior Criminal Proceeding) in the case of Mayor Ras Baraka. You can use the email dcjtipline@njdcj.org. Let him know you think Alina Habba has violated 3.12 by arresting and then dropping the case against Mayor Baraka, and that her actions satisfy the elements of malicious prosecution action based upon a prior criminal proceeding.Find Upcoming Demonstrations And Actions:50501 MovementJune 14th Nationwide Demonstrations - NoKings.orgIndivisible.orgFederal workers - feel free to email me at fedoath@pm.me and let me know what you're going to do, or just vent. I'm always here to listen. Share your Good News or Good Trouble:dailybeanspod.com/goodFrom The Good NewsAdd or Manage a Security Freeze | InnovisThe Man Who Calculated Deaththreads.com/@indivisiblebuckscoDogs i pet (@dogs__i__pet) • InstagramReminder - you can see the pod pics if you become a Patron. The good news pics are at the bottom of the show notes of each Patreon episode! That's just one of the perks of subscribing! patreon.com/muellershewrote Mega Happy Hour Zoom Call - you can interact with not just me and Harry Dunn, Andy McCabe, and Dana Goldberg. They'll all be there this Friday 5/23/2025 at 7 PM ET 4 PM PT. Plus, you'll get these episodes ad free and early, and get pre-sale tickets and VIP access to our live events. You can join at patreon.com/muellershewrote for as little as $3 a month. Federal workers - feel free to email me at fedoath@pm.me and let me know what you're going to do, or just vent. I'm always here to listen.Share your Good News or Good Trouble:https://www.dailybeanspod.com/good/ Check out other MSW Media podcastshttps://mswmedia.com/shows/Subscribe for free to MuellerSheWrote on Substackhttps://muellershewrote.substack.comFollow AG and Dana on Social MediaDr. Allison Gill Substack|Muellershewrote, BlueSky|@muellershewrote , Threads|@muellershewrote, TikTok|@muellershewrote, IG|muellershewrote, Twitter|@MuellerSheWrote,Dana GoldbergTwitter|@DGComedy, IG|dgcomedy, facebook|dgcomedy, IG|dgcomedy, danagoldberg.com, BlueSky|@dgcomedyHave some good news; a confession; or a correction to share?Good News & Confessions - The Daily Beanshttps://www.dailybeanspod.com/confessional/ Listener Survey:http://survey.podtrac.com/start-survey.aspx?pubid=BffJOlI7qQcF&ver=shortFollow the Podcast on Apple:The Daily Beans on Apple PodcastsWant to support the show and get it ad-free and early?Supercasthttps://dailybeans.supercast.com/Patreon https://patreon.com/thedailybeansOr subscribe on Apple Podcasts with our affiliate linkThe Daily Beans on Apple Podcasts

20 de  mayo último día para registro al programa “Alimentación para el Bienestar”  Avanza en comisiones de San Lázaro la salida obligatoria del domicilio conyugal de agresor  Futuro de la rectoría de la UAEMex se define el 30 de mayo   Más información en nuestro podcast

00:04:47:07 - 00:16:34:22Argentine President Javier Milei overhauls immigration system to curb illegal migration, ban criminals, and mandate health service payments. Host supports stricter policies, arguing unchecked immigration erodes cultural identity and burdens taxpayers.00:16:35:00 - 00:28:43:00Eric Peters' article critiques property taxes as preventing true homeownership, forcing perpetual payments like rent to the government. Host compares modern homeowners to feudal serfs, emphasizing loss of freedom.00:52:02:14 - 01:01:50:11Trump moves to rescind appliance efficiency standards, which host argues make appliances less functional, costlier, and less reliable. Regulations favor large companies, limiting consumer choice and innovation.01:09:04:20 - 01:29:39:06New American article critiques statues of generic black women replacing historical figures like Thomas Jefferson in Times Square, arguing they celebrate mediocrity and erase history. Contrasts with statues of Father Francis Duffy and George M. Cohan, honored for significant achievements. Links to Marxist tactics and cultural decline, emphasizing identity politics over merit and history's role in identity.01:35:17:01 - 01:39:06:02Fort Detrick bio lab shut down after a researcher deliberately damaged another's containment suit over a lover's quarrel, risking pathogen leaks. Highlights poor safety culture and unqualified personnel in critical government roles, questioning the existence of such labs.01:50:45:18 - 01:55:04:15Trump administration considers suspending habeas corpus for immigration cases, threatening constitutional rights. Habeas corpus ensures individuals can challenge detention legality, and suspension risks authoritarianism, undermining fundamental human rights.02:23:36:07 - 02:31:24:22Celente critiques global leaders and Germany's $1 trillion military buildup, ignoring its recession and historical aggression. Host details U.S. provocation in Ukraine via NATO expansion and regime change, fueling Russian response. Both condemn U.S. callousness toward Ukraine's suffering, warning of cultural and human losses in a potential European war.02:36:46:05 - 02:43:02:09Celente predicts a dot-com bust 2.0 due to overvalued AI stocks, citing Chinese efficiency (DeepSeek's $6M vs. $100M costs). Forecasts office building bust from remote work, with 20% vacancy in major U.S. cities, leading to bank failures. Remains bullish on gold despite price dips.02:50:55:23 - 02:56:05:20Host and Celente denounce Israel's actions in Gaza, citing over 100 daily civilian deaths and child maiming. Criticize Trump and Kushner for viewing Gaza as exploitable land, ignoring Palestinian history. Celente refutes anti-Semitism claims, noting Jewish opposition to Israel's policies.Follow the show on Kick and watch live every weekday 9:00am EST – 12:00pm EST https://kick.com/davidknightshow Money should have intrinsic value AND transactional privacy: Go to https://davidknight.gold/ for great deals on physical gold/silver For 10% off Gerald Celente's prescient Trends Journal, go to https://trendsjournal.com/ and enter the code KNIGHT Find out more about the show and where you can watch it at TheDavidKnightShow.comIf you would like to support the show and our family please consider subscribing monthly here: SubscribeStar https://www.subscribestar.com/the-david-knight-showOr you can send a donation throughMail: David Knight POB 994 Kodak, TN 37764Zelle: @DavidKnightShow@protonmail.comCash App at: $davidknightshowBTC to: bc1qkuec29hkuye4xse9unh7nptvu3y9qmv24vanh7Become a supporter of this podcast: https://www.spreaker.com/podcast/the-david-knight-show--2653468/support.

00:04:47:07 - 00:16:34:22Argentine President Javier Milei overhauls immigration system to curb illegal migration, ban criminals, and mandate health service payments. Host supports stricter policies, arguing unchecked immigration erodes cultural identity and burdens taxpayers.00:16:35:00 - 00:28:43:00Eric Peters' article critiques property taxes as preventing true homeownership, forcing perpetual payments like rent to the government. Host compares modern homeowners to feudal serfs, emphasizing loss of freedom.00:52:02:14 - 01:01:50:11Trump moves to rescind appliance efficiency standards, which host argues make appliances less functional, costlier, and less reliable. Regulations favor large companies, limiting consumer choice and innovation.01:09:04:20 - 01:29:39:06New American article critiques statues of generic black women replacing historical figures like Thomas Jefferson in Times Square, arguing they celebrate mediocrity and erase history. Contrasts with statues of Father Francis Duffy and George M. Cohan, honored for significant achievements. Links to Marxist tactics and cultural decline, emphasizing identity politics over merit and history's role in identity.01:35:17:01 - 01:39:06:02Fort Detrick bio lab shut down after a researcher deliberately damaged another's containment suit over a lover's quarrel, risking pathogen leaks. Highlights poor safety culture and unqualified personnel in critical government roles, questioning the existence of such labs.01:50:45:18 - 01:55:04:15Trump administration considers suspending habeas corpus for immigration cases, threatening constitutional rights. Habeas corpus ensures individuals can challenge detention legality, and suspension risks authoritarianism, undermining fundamental human rights.02:23:36:07 - 02:31:24:22Celente critiques global leaders and Germany's $1 trillion military buildup, ignoring its recession and historical aggression. Host details U.S. provocation in Ukraine via NATO expansion and regime change, fueling Russian response. Both condemn U.S. callousness toward Ukraine's suffering, warning of cultural and human losses in a potential European war.02:36:46:05 - 02:43:02:09Celente predicts a dot-com bust 2.0 due to overvalued AI stocks, citing Chinese efficiency (DeepSeek's $6M vs. $100M costs). Forecasts office building bust from remote work, with 20% vacancy in major U.S. cities, leading to bank failures. Remains bullish on gold despite price dips.02:50:55:23 - 02:56:05:20Host and Celente denounce Israel's actions in Gaza, citing over 100 daily civilian deaths and child maiming. Criticize Trump and Kushner for viewing Gaza as exploitable land, ignoring Palestinian history. Celente refutes anti-Semitism claims, noting Jewish opposition to Israel's policies.Follow the show on Kick and watch live every weekday 9:00am EST – 12:00pm EST https://kick.com/davidknightshow Money should have intrinsic value AND transactional privacy: Go to https://davidknight.gold/ for great deals on physical gold/silver For 10% off Gerald Celente's prescient Trends Journal, go to https://trendsjournal.com/ and enter the code KNIGHT Find out more about the show and where you can watch it at TheDavidKnightShow.comIf you would like to support the show and our family please consider subscribing monthly here: SubscribeStar https://www.subscribestar.com/the-david-knight-showOr you can send a donation throughMail: David Knight POB 994 Kodak, TN 37764Zelle: @DavidKnightShow@protonmail.comCash App at: $davidknightshowBTC to: bc1qkuec29hkuye4xse9unh7nptvu3y9qmv24vanh7Become a supporter of this podcast: https://www.spreaker.com/podcast/the-real-david-knight-show--5282736/support.

On this episode of The Daily Herold, Jon Herold kicks things off with an in-depth segment featuring Ghost of Patrick Henry to unpack the geopolitical power plays redefining the Middle East. From Trump's surprising snub of Israel and the sidelining of Netanyahu, to renewed talks with Iran and a potentially historic Saudi nuclear deal, the duo digs deep into the motives and strategies behind Trump's emerging peace-through-strength doctrine. Ghost connects the dots on Jared Kushner's quiet return, Ron Dermer's desperation visit to D.C., and why a Trump-Putin handshake in Riyadh could flip the entire global narrative. Back on the homefront, Jon recaps the shakeup at DOJ, where Judge Jeanine Pirro replaces Ed Martin as interim U.S. Attorney for D.C., a move likely designed to expose more RINO obstruction in the Senate. Meanwhile, Martin slides into a powerful new triple-threat role leading pardons, investigating government weaponization, and serving as Associate Deputy AG. The episode also takes aim at James O'Keefe's overhyped Epstein “exposé,” calling out the clickbait tactics and flimsy accusations against Pam Bondi as a reckless distraction. Jon defends Dr. Casey Means, Trump's pick for Surgeon General, applauding her credentials as a fearless disruptor and dismantling the absurd arguments about her inactive license. Rounding out the show are sharp takes on Jasmine Crockett's projection-fueled rant, Letitia James' federal probe, the firing of FEMA's acting director, and a liberal meltdown over overpriced tacos. Herold weaves it all together with narrative warfare analysis and a reminder that chaos is just the prelude to clarity.

Products often tell you exactly how they're intended to be used. But why leave it at that? As a culture, we have long had a knack for finding ingenious, off-label uses for things. In this episode, we take a close look at a few examples of products that are ostensibly meant for one thing, but are better known for something else entirely. We explore Q-tips, which we are explicitly told not to put into our ears; the Hitachi Magic Wand, the iconic sex toy marketed as a body massager; the musical washboard; and the children's electrolyte solution Pedialyte that many adults swear by as a hangover cure. You'll hear from Hallie Lieberman, author of Buzz: A Stimulating History of the Sex Toy; Jacqui Barnett of the Columbus Washboard Company; Christopher Wilson, curator and chair of the Division of Home and Community Life at the Smithsonian; musician and educator Súle Greg Wilson; zydeco musicians C.J. Chenier and Steve Nash; Shaughnessy Bishop-Stall, author of Hungover: The Morning After and One Man's Quest for the Cure; as well as writers Roberto Ferdman, Dan Brooks, and Kaitlyn Tiffany. Decoder Ring is produced by Willa Paskin, Max Freedman, Katie Shepherd, and Evan Chung, Decoder Ring's supervising producer. We had additional production from Sofie Kodner. Merritt Jacob is Senior Technical Director. Special thanks to Kate Sloan, Dr. Carol Queen, Bryony Cole, Amber Singer, Molly Born, Laura Selikson, and Nell McShane Wulfhart. If you have any cultural mysteries you want us to decode, please email us at DecoderRing@slate.com, or leave a message on our hotline at 347-460-7281. Sources for This Episode Bishop-Stall, Shaughnessy. Hungover: The Morning After and One Man's Quest for the Cure, Penguin, 2018. Brooks, Dan. “Letter of Recommendation: Pedialyte,” New York Times Magazine, Jan. 26, 2017. Comella, Lynn. Vibrator Nation: How Feminist Sex-Toy Stores Changed the Business of Pleasure, Duke University Press, 2017. Dodson, Betty. “Having Sex with Machines: The Return of the Electric Vibrator,” Dodson and Ross, June 9, 2010. Feran, Tim. “Pedialyte Is Not Just For Kids,” Columbus Dispatch, July 19, 2015. Ferdman, Roberto A. “The strange life of Q-tips, the most bizarre thing people buy,” Washington Post, Jan. 20, 2016. Kushner, David. “Inside Orgasmatron,” Village Voice, March 26, 1999. Lieberman, Hallie. Buzz: A Stimulating History of the Sex Toy, Pegasus Books, 2017. Lieberman, Hallie. “Selling Sex Toys: Marketing and the Meaning of Vibrators in Early Twentieth-Century America,” Enterprise & Society, June 2016. Russel, Ruth. “Hangover Remedies? I'll Drink to That!,” Idaho Statesman, Jan. 1, 1978. Sloan, Kate. Making Magic, 2024. Tiffany, Kaitlyn. “How Pedialyte got Pedialit,” Vox, Sep. 10, 2018. Williams, Dell. “The Roots of the Garden,” Journal of Sex Research, August 1990. Wulfhart, Nell McShane. “The Best Hangover Cure,” Slate, Aug. 29, 2013. Want more Decoder Ring? Subscribe to Slate Plus to unlock exclusive bonus episodes. Plus, you'll access ad-free listening across all your favorite Slate podcasts. Subscribe now on Apple Podcasts by clicking “Try Free” at the top of the Decoder Ring show page. Or, visit slate.com/decoderplus to get access wherever you listen. Learn more about your ad choices. Visit megaphone.fm/adchoices

Products often tell you exactly how they're intended to be used. But why leave it at that? As a culture, we have long had a knack for finding ingenious, off-label uses for things. In this episode, we take a close look at a few examples of products that are ostensibly meant for one thing, but are better known for something else entirely. We explore Q-tips, which we are explicitly told not to put into our ears; the Hitachi Magic Wand, the iconic sex toy marketed as a body massager; the musical washboard; and the children's electrolyte solution Pedialyte that many adults swear by as a hangover cure. You'll hear from Hallie Lieberman, author of Buzz: A Stimulating History of the Sex Toy; Jacqui Barnett of the Columbus Washboard Company; Christopher Wilson, curator and chair of the Division of Home and Community Life at the Smithsonian; musician and educator Súle Greg Wilson; zydeco musicians C.J. Chenier and Steve Nash; Shaughnessy Bishop-Stall, author of Hungover: The Morning After and One Man's Quest for the Cure; as well as writers Roberto Ferdman, Dan Brooks, and Kaitlyn Tiffany. Decoder Ring is produced by Willa Paskin, Max Freedman, Katie Shepherd, and Evan Chung, Decoder Ring's supervising producer. We had additional production from Sofie Kodner. Merritt Jacob is Senior Technical Director. Special thanks to Kate Sloan, Dr. Carol Queen, Bryony Cole, Amber Singer, Molly Born, Laura Selikson, and Nell McShane Wulfhart. If you have any cultural mysteries you want us to decode, please email us at DecoderRing@slate.com, or leave a message on our hotline at 347-460-7281. Sources for This Episode Bishop-Stall, Shaughnessy. Hungover: The Morning After and One Man's Quest for the Cure, Penguin, 2018. Brooks, Dan. “Letter of Recommendation: Pedialyte,” New York Times Magazine, Jan. 26, 2017. Comella, Lynn. Vibrator Nation: How Feminist Sex-Toy Stores Changed the Business of Pleasure, Duke University Press, 2017. Dodson, Betty. “Having Sex with Machines: The Return of the Electric Vibrator,” Dodson and Ross, June 9, 2010. Feran, Tim. “Pedialyte Is Not Just For Kids,” Columbus Dispatch, July 19, 2015. Ferdman, Roberto A. “The strange life of Q-tips, the most bizarre thing people buy,” Washington Post, Jan. 20, 2016. Kushner, David. “Inside Orgasmatron,” Village Voice, March 26, 1999. Lieberman, Hallie. Buzz: A Stimulating History of the Sex Toy, Pegasus Books, 2017. Lieberman, Hallie. “Selling Sex Toys: Marketing and the Meaning of Vibrators in Early Twentieth-Century America,” Enterprise & Society, June 2016. Russel, Ruth. “Hangover Remedies? I'll Drink to That!,” Idaho Statesman, Jan. 1, 1978. Sloan, Kate. Making Magic, 2024. Tiffany, Kaitlyn. “How Pedialyte got Pedialit,” Vox, Sep. 10, 2018. Williams, Dell. “The Roots of the Garden,” Journal of Sex Research, August 1990. Wulfhart, Nell McShane. “The Best Hangover Cure,” Slate, Aug. 29, 2013. Want more Decoder Ring? Subscribe to Slate Plus to unlock exclusive bonus episodes. Plus, you'll access ad-free listening across all your favorite Slate podcasts. Subscribe now on Apple Podcasts by clicking “Try Free” at the top of the Decoder Ring show page. Or, visit slate.com/decoderplus to get access wherever you listen. Learn more about your ad choices. Visit megaphone.fm/adchoices

Products often tell you exactly how they're intended to be used. But why leave it at that? As a culture, we have long had a knack for finding ingenious, off-label uses for things. In this episode, we take a close look at a few examples of products that are ostensibly meant for one thing, but are better known for something else entirely. We explore Q-tips, which we are explicitly told not to put into our ears; the Hitachi Magic Wand, the iconic sex toy marketed as a body massager; the musical washboard; and the children's electrolyte solution Pedialyte that many adults swear by as a hangover cure. You'll hear from Hallie Lieberman, author of Buzz: A Stimulating History of the Sex Toy; Jacqui Barnett of the Columbus Washboard Company; Christopher Wilson, curator and chair of the Division of Home and Community Life at the Smithsonian; musician and educator Súle Greg Wilson; zydeco musicians C.J. Chenier and Steve Nash; Shaughnessy Bishop-Stall, author of Hungover: The Morning After and One Man's Quest for the Cure; as well as writers Roberto Ferdman, Dan Brooks, and Kaitlyn Tiffany. Decoder Ring is produced by Willa Paskin, Max Freedman, Katie Shepherd, and Evan Chung, Decoder Ring's supervising producer. We had additional production from Sofie Kodner. Merritt Jacob is Senior Technical Director. Special thanks to Kate Sloan, Dr. Carol Queen, Bryony Cole, Amber Singer, Molly Born, Laura Selikson, and Nell McShane Wulfhart. If you have any cultural mysteries you want us to decode, please email us at DecoderRing@slate.com, or leave a message on our hotline at 347-460-7281. Sources for This Episode Bishop-Stall, Shaughnessy. Hungover: The Morning After and One Man's Quest for the Cure, Penguin, 2018. Brooks, Dan. “Letter of Recommendation: Pedialyte,” New York Times Magazine, Jan. 26, 2017. Comella, Lynn. Vibrator Nation: How Feminist Sex-Toy Stores Changed the Business of Pleasure, Duke University Press, 2017. Dodson, Betty. “Having Sex with Machines: The Return of the Electric Vibrator,” Dodson and Ross, June 9, 2010. Feran, Tim. “Pedialyte Is Not Just For Kids,” Columbus Dispatch, July 19, 2015. Ferdman, Roberto A. “The strange life of Q-tips, the most bizarre thing people buy,” Washington Post, Jan. 20, 2016. Kushner, David. “Inside Orgasmatron,” Village Voice, March 26, 1999. Lieberman, Hallie. Buzz: A Stimulating History of the Sex Toy, Pegasus Books, 2017. Lieberman, Hallie. “Selling Sex Toys: Marketing and the Meaning of Vibrators in Early Twentieth-Century America,” Enterprise & Society, June 2016. Russel, Ruth. “Hangover Remedies? I'll Drink to That!,” Idaho Statesman, Jan. 1, 1978. Sloan, Kate. Making Magic, 2024. Tiffany, Kaitlyn. “How Pedialyte got Pedialit,” Vox, Sep. 10, 2018. Williams, Dell. “The Roots of the Garden,” Journal of Sex Research, August 1990. Wulfhart, Nell McShane. “The Best Hangover Cure,” Slate, Aug. 29, 2013. Want more Decoder Ring? Subscribe to Slate Plus to unlock exclusive bonus episodes. Plus, you'll access ad-free listening across all your favorite Slate podcasts. Subscribe now on Apple Podcasts by clicking “Try Free” at the top of the Decoder Ring show page. Or, visit slate.com/decoderplus to get access wherever you listen. Learn more about your ad choices. Visit megaphone.fm/adchoices

Products often tell you exactly how they're intended to be used. But why leave it at that? As a culture, we have long had a knack for finding ingenious, off-label uses for things. In this episode, we take a close look at a few examples of products that are ostensibly meant for one thing, but are better known for something else entirely. We explore Q-tips, which we are explicitly told not to put into our ears; the Hitachi Magic Wand, the iconic sex toy marketed as a body massager; the musical washboard; and the children's electrolyte solution Pedialyte that many adults swear by as a hangover cure. You'll hear from Hallie Lieberman, author of Buzz: A Stimulating History of the Sex Toy; Jacqui Barnett of the Columbus Washboard Company; Christopher Wilson, curator and chair of the Division of Home and Community Life at the Smithsonian; musician and educator Súle Greg Wilson; zydeco musicians C.J. Chenier and Steve Nash; Shaughnessy Bishop-Stall, author of Hungover: The Morning After and One Man's Quest for the Cure; as well as writers Roberto Ferdman, Dan Brooks, and Kaitlyn Tiffany. Decoder Ring is produced by Willa Paskin, Max Freedman, Katie Shepherd, and Evan Chung, Decoder Ring's supervising producer. We had additional production from Sofie Kodner. Merritt Jacob is Senior Technical Director. Special thanks to Kate Sloan, Dr. Carol Queen, Bryony Cole, Amber Singer, Molly Born, Laura Selikson, and Nell McShane Wulfhart. If you have any cultural mysteries you want us to decode, please email us at DecoderRing@slate.com, or leave a message on our hotline at 347-460-7281. Sources for This Episode Bishop-Stall, Shaughnessy. Hungover: The Morning After and One Man's Quest for the Cure, Penguin, 2018. Brooks, Dan. “Letter of Recommendation: Pedialyte,” New York Times Magazine, Jan. 26, 2017. Comella, Lynn. Vibrator Nation: How Feminist Sex-Toy Stores Changed the Business of Pleasure, Duke University Press, 2017. Dodson, Betty. “Having Sex with Machines: The Return of the Electric Vibrator,” Dodson and Ross, June 9, 2010. Feran, Tim. “Pedialyte Is Not Just For Kids,” Columbus Dispatch, July 19, 2015. Ferdman, Roberto A. “The strange life of Q-tips, the most bizarre thing people buy,” Washington Post, Jan. 20, 2016. Kushner, David. “Inside Orgasmatron,” Village Voice, March 26, 1999. Lieberman, Hallie. Buzz: A Stimulating History of the Sex Toy, Pegasus Books, 2017. Lieberman, Hallie. “Selling Sex Toys: Marketing and the Meaning of Vibrators in Early Twentieth-Century America,” Enterprise & Society, June 2016. Russel, Ruth. “Hangover Remedies? I'll Drink to That!,” Idaho Statesman, Jan. 1, 1978. Sloan, Kate. Making Magic, 2024. Tiffany, Kaitlyn. “How Pedialyte got Pedialit,” Vox, Sep. 10, 2018. Williams, Dell. “The Roots of the Garden,” Journal of Sex Research, August 1990. Wulfhart, Nell McShane. “The Best Hangover Cure,” Slate, Aug. 29, 2013. Want more Decoder Ring? Subscribe to Slate Plus to unlock exclusive bonus episodes. Plus, you'll access ad-free listening across all your favorite Slate podcasts. Subscribe now on Apple Podcasts by clicking “Try Free” at the top of the Decoder Ring show page. Or, visit slate.com/decoderplus to get access wherever you listen. Learn more about your ad choices. Visit megaphone.fm/adchoices

Former Meet the Press host Chuck Todd joins to talk about his new podcast, The Chuck Toddcast. He discusses why being a non-pushover and being non-partisan are complimentary, and what too many ex-network stars get wrong about "liberation." Also how Priebus, Pence, and Kushner acted as guardrails whereas Trump 2.0 feels more like a solo demolition derby. Plus: Kristen Welker's Trump interview somehow included dolls, gas prices under $2, and not ruling out war with Canada. And in The Spiel: if California wants just 35% of car sales to be gas-powered by 2026, how exactly do they plan to enforce it? Learn more about your ad choices. Visit podcastchoices.com/adchoices

Thanks Nachum, With Pesach break over, the Spring seasons are winding their way down toward the playoffs. Straight ahead on Tuesday Morning JM in the AM Sports Update, Varsity Girls Hockey sees a 36 hour shakeup out West, Division leaders collide this coming weekend in Boys Varsity Softball and the longest current win streak in Yeshiva League boys sports is no more. All that and more straight ahead, good morning, I'm Elliot Weiselberg. We start off today's update with a Jeopardy question. The category: Boys Volleyball, Answer: June 12, 2022. The correct question: When was the last time that the Ramaz Rams suffered a loss? Or...it was the correct answer until this past Sunday. The Rams entered their contest with the SAR Sting riding a 24 game winning streak. In the majority of those contests, Ramaz was the recipient of several sweep victories. On this day, the tables would turn and the Sting would sweep Ramaz 21 to 12, 14 and ultimately 18 to put an end to the longest active winning streak in Boys sports. SAR now sits atop the West at 5-1 with Ramaz behind them at 4-1. Some added insight on that last Ramaz loss, it was to the same SAR Sting in the 2022 semifinals. So for those curious, the last time that Ramaz lost a regular season contest? Pre-covid. In Boys Softball, DRS made a statement this past Friday dominating Nishmas HaTorah in both contests to improve to 4-1 and drop Nishmas to 3-3. The Wildcats will gear up to face their biggest challenge so far when they meet May this coming Friday. May sits at 2-0 and will start the heart of their schedule with either a win that could propel them toward a division crown, or give DRS a heads-up in that race. Out West, Hillel stays undefeated drubbing Frisch this past Sunday to improve to 4-0. They'll square off with Shaare Torah tomorrow night, but the real contest for them will be this coming Sunday when they host Central division leading YDE, also at 4-0. In Girls hockey, a mad 36 hour stretch saw quite a few changes in the top 6 slots. Sunday saw the Frisch Cougars extend their lead in the West with a 5-1 win over Heschel who entered the day in the 2nd slot in the West. Meanwhile, Frisch's rival Ramaz took a 6-1 victory over SKA to improve to 4-1-0-1 and last night Ma'ayanot shutout East leading HAFTR 2-0. So the West leading Cougars are now a point away from clinching the Top seed in the playoffs and can do so against HAFTR who at 4-1-0-1 look to have the East all but put away themselves. Behind Frisch, Ramaz jumps to 2nd place, Ma'ayanot to 3rd and Heschel drops to 4th, only one point ahead of SAR and 2 ahead of Kushner with all teams still in play for the 4 wildcard spots over the next week. Finally, we are very proud to announce that the Martin Weiselberg Memorial Junior High Hockey Tournament is back and ready to roll with its 18th tournament on June 15th in HAFTR. Middle School teams will do battle in the longest-running hockey tournament in the Yeshiva Leagues while raising money for Hatzolah. Of course this also means the return of the amazing memorabilia raffle, which has seen items signed by present and future hall of famers, including Gordie Howe, Mark Messier and new goal-scoring king Alex Ovechkin. We will announce teams, prizes and schedules over the next few weeks on our website at MWTournament.com. And that was your Tuesday Morning JM in the AM Sports Update, I'm Elliot Weiselberg

It's always uplifting to hear how some people are inspired to turn the worst experience into something positive to help others. Join us to hear Alli's story of postpartum depression, healing, and a remarkable avenue of support and connection for other moms.  Alli Kushner is an entrepreneur, community builder, and passionate advocate for parents navigating the complexities of modern life. As the founder of⁠ BeeKyn⁠, an innovative platform that reimagines how families connect through meaningful playdates, Alli is on a mission to make parenthood less isolating and more fulfilling. Alli is the mother of two young girls and shares her deeply personal journey through postpartum depression. The challenges she faced became the opportunity to create a supportive space for parents everywhere in BeeKyn.  Show Highlights: Alli's story: what she expected vs. her reality in becoming a mom An unexpected identity crisis  Pregnancy problems that threw “the plan” out the window for Alli's first pregnancy Knowing things weren't “right”  Alli's recognition of “baby blues” (which later turned into PPD) The gap in Ob-gyn and pediatric care when a healthy baby arrives, but mom is not okay Alli's experience in returning to work earlier than necessary, because that was the world she understood and could control Feeling numb, angry, and unsure about motherhood, just wanting to get away (for the first six months) Feeling like “everyone would be better off without me” How Alli's husband insisted that she get professional help because he didn't know how to help her Alli's “Aha moment” on an outing in NYC, realizing that this is “not normal” How Alli noticed the slow unfolding of improvement as the result of a daily therapy/rehab program Sharing her story helped Alli realize the need for more attention on postpartum depression and the feelings of isolation and loneliness The benefits of BeeKyn's platform for families Resources: Connect with Alli Kushner and BeeKyn:⁠ Website⁠ and⁠ LinkedIn⁠ Call the National Maternal Mental Health Hotline at 1-833-TLC-MAMA or visit⁠ cdph.ca.gov⁠ Please find resources in English and Spanish at⁠ Postpartum Support International⁠, or by phone/text at 1-800-944-4773. There are many free resources, like online support groups, peer mentors, a specialist provider directory, and perinatal mental health training for therapists, physicians, nurses, doulas, and anyone who wants to be more supportive in offering services.  You can also follow PSI on social media:⁠ Instagram⁠,⁠ Facebook⁠, and most other platforms Visit⁠ www.postpartum.net/professionals/certificate-trainings/⁠ for information on the grief course.   Visit my website,⁠ www.wellmindperinatal.com⁠, for more information, resources, and courses you can take today! If you are a California resident looking for a therapist in perinatal mental health, email me⁠ about openings for private pay clients! Learn more about your ad choices. Visit podcastchoices.com/adchoices

In this episode of "F-Stop Collaborate and Listen," host Matt Payne engages in a captivating conversation with Sara Kushner, a talented self-portrait photographer with 16 years of experience. Sara delves into her journey, explaining how self-portraiture functions as a form of therapy, allowing her to process emotions and express vulnerability. She contrasts her art with the influencer-driven self-portrait culture, emphasizing authenticity and artistic intent. The discussion also touches on Sara's dual role as an anti-diet registered dietitian, her plans to combine her passions in future workshops, and the technical aspects and emotional depth of self-portrait photography. Sara shares how she navigates judgment and the unique blend of landscape and self-portraiture in her work, striving to evoke emotions and authenticity in her audience. Links: Follow Sara on Instagram Stay connected with Sara on her newsletter Learn more about the Natural Landscape Photography Awards Stay connected with Matt on his newsletter Support the podcast on Patreon Sara's offering 10% our listeners/watchers on her prints, use the code FSTOP10 Sara's recommended photographers: Katie Lingan, Van Gachnang

Shiur @ Kushner Yeshiva High School in Growth by Rabbi Daniel Kalish

Rabbi Kalish

In this episode of Predictable B2B Success, host Vinay Koshy welcomes Daniel Kushner, CEO and co-founder of Oktopost, a sophisticated social media management and employee advocacy platform. With his rich background as a serial entrepreneur, Kushner dives deep into the intricacies of measuring and monetizing B2B social media to demonstrate its tangible impact on business success. Discover the fascinating story behind Oktopost's inception in 2013, born out of a personal need for better measurement tools in the social media space. As the discussion unfolds, Kushner reveals the profound differences between B2B and B2C social media, advocating for a holistic approach where social engagement is a cross-organizational effort rather than a marketing silo. The episode explores the importance of integrating social media into the overall fabric of a company—underscoring the need for businesses to embrace social at a cultural level to maximize opportunities. Additionally, Kushner unpacks the role of employee advocacy, offers insights for startups with smaller teams, and shares valuable advice on nurturing thought leadership within technical teams. Please tune in to explore how AI, data trends, and authentic engagement are reshaping the landscape of B2B social media and why measuring its impact should be at the forefront of any forward-thinking organization. Some areas we explore in this episode include: Origin of Oktopost: Founding of Oktopost in 2013 and the market opportunity identified.Measuring Social Media Impact: Importance of measuring social media's influence on B2B success.Platform Integration: Need for tools like Oktopost to integrate with other marketing platforms.Cross-Organizational Social Engagement: Social media's role across different organizational functions.Organizational Culture: Impact of culture and leadership on social media effectiveness.Challenges for Startups: Strategies for smaller companies to leverage social media.Employee Advocacy: Role of employees in brand promotion and thought leadership.Personal Branding: Supporting employees in building personal brands through social media.B2B vs. B2C Social Media: Differences in approach between B2B and B2C social media.AI's Role: How AI can enhance social media strategies and trend analysis.And much, much more...

We're joined this week by Brian's longtime friend, inspirational artist, and glitter enthusiast, Jamie Kushner Blicher. Jamie started creating mixed-media […] The post Turning Pain Into Glitter with Jamie Kushner Blicher appeared first on Queer Theology.

Described by Mick Herron as ‘seductive, entrancing, and quite off the wall', Rachel Kushner's fourth novel Creation Lake (Cape) reaffirms her position as one of America's most exciting and accomplished writers of fiction. In a reimagining of the spy novel for an age of ecological crisis, Kushner leads us to a remote Neanderthal cave in rural France where the enigmatic Bruno Lacombe leads his followers in a radical project to reject and undermine the modern world. ‘I've never read anything like it', writes Brett Easton Ellis. Rachel Kushner was joined in conversation by the novelist and critic Adam Thirlwell.Find more events at the Bookshop: https://lrb.me/eventspodGet Creation Lake: https://lrb.me/creationlakepod Hosted on Acast. See acast.com/privacy for more information.

durée : 00:51:47 - Le Masque et la Plume - par : Rebecca Manzoni - La rupture des promesses entre deux amants ; une ex-agente du FBI infiltre un réseau d'éco-activiste ; un écrivain confronté à la disparition de son fils ; une enquête sur une série de meurtres ciblant de jeunes homosexuels ; le voyage d'une danseuse en car à travers l'Europe pour faire son deuil. - invités : Jean-Marc Proust, Laurent CHALUMEAU, Raphaelle Leyris, Patricia Martin - Jean-Marc Proust : Auteur et critique (Slate), Laurent Chalumeau : Journaliste rock, scénariste, dialoguiste, romancier, Raphaëlle Leyris : Journaliste au Monde, critique littéraire, Patricia Martin : Journaliste, critique littéraire et productrice chez France Inter - réalisé par : Guillaume Girault

Shiur given by Rabbi Zisha Kushner on Parshas Mishpatim as a guest speaker in Yeshiva. Shiur recorded in Yeshivas Ohr Reuven, Monsey, NY.

Defining "obesity" is not straightforward. Using body mass index (BMI) alone may miss some unhealthy individuals and mislabel others. New global clinical recommendations aim to improve the definition of obesity. The Lancet Diabetes & Endocrinology Commission, supported by 75 medical organizations, proposes to use objective measures of illness based on individual risk factors. Dr. Kushner states that these recommendations represent a significant advancement in recognizing obesity as a disease rather than just a risk factor, allowing clinicians to identify those in need of treatment.

In the past week Trump issued four announcements that continue to portend a radical restructuring of the US imperial system. First: US proposes to ‘own' GAZA, allowing Israel to focus on future expansion into Syria, west bank & Lebanon, and shift its policy from genocide to ethnic cleansing. The role of Trump son-in-law Kushner's US-Israel real estate consortium behind the scenes. Second, Trump holds 90 min. talk with Putin, followed by 10 min. with Zelensky, while ignoring the Europeans who in response are now freaking out. Third, Trump announces escalation of US tariff weapon by introducing principle of ‘reciprocal' tariffs with all US trading partners + offers rollback of US use of sanctions. Fourth, Trump offers Russia to rejoin US SWIFT international payments system, then threatens BRICS with 100% tariffs if they abandon the US $ in trade, declaring thereafter ‘the BRICS are dead!'. Show concludes what we are witnessing is the beginning of the restructuring of US imperial relations abroad, while simultaneously the Trump government takes on the US bureaucratic State apparatus bloated by empire to reduce its power and influence over the government.

Jewish Faith & Jewish Facts with Rabbi Steven Garten. Aired: February 16th, 2025 on CHRI Radio 99.1FM in Ottawa, Canada. For questions, email Rabbi Garten at rabbishg@templeisraelottawa.com For more CHRI shows, visit chri.ca

Just 48 hours after squeaking out a victory against Pitt (14:14), Carolina failed to meet the Tar Heel basketball standard at Clemson (4:38)UNC grad and military flight surgeon Dr. Hal Kushner joins for an incredible interview to discuss his time as a POW in the Vietnam War (24:44)Plus: an awesome dad moment in Story Time (1:32:39)See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Kash Patel's Confirmation Vote DELAYED… But Does It Matter? Judge PAUSES Trump's Federal Worker Buyout Plan. REVEALED: Jared Kushner Has $$$ In Firm Involved With Israeli Settlements. Attorney General Pam Bondi Goes After Sanctuary Cities. Hosts: Ana Kasparian, Cenk Uygur SUBSCRIBE on YOUTUBE ☞ https://www.youtube.com/@TheYoungTurks FOLLOW US ON: FACEBOOK ☞ https://www.facebook.com/theyoungturks TWITTER ☞ https://twitter.com/TheYoungTurks INSTAGRAM ☞ https://www.instagram.com/theyoungturks TIKTOK ☞ https://www.tiktok.com/@theyoungturks

Donald Trump plans to ethnically cleanse Palestinians, saying, "The US will take over the Gaza Strip... We'll own it". His son-in-law Jared Kushner has invested in Israeli companies that profit from expanding illegal settlements. Trump and Kushner floated building luxury real estate in Gaza. Ben Norton reports. VIDEO: https://www.youtube.com/watch?v=HMBwV8kL5NY Topics 0:00 Trump is Israel's "best friend" 1:04 US plans to "take over" Gaza 2:19 Trump's son-in-law Jared Kushner 3:04 Rebuilding Gaza 3:45 Gaza's "phenomenal location on the sea" 4:24 Kushner eyes "Gaza's waterfront property" 5:05 Ethnic cleansing 5:52 Kushner's investments in Israel 6:51 Saudi Arabia invests in Kushner's firm 8:29 Israel proposes Saudi land for Palestinians 10:00 Trump pressures Jordan & Egypt 11:07 Plans to expel "all" Gazans 11:38 Gaza death toll 13:08 US-Israel made Gaza "Hell" 14:11 Biden vs Trump 15:01 Palestinians don't want to leave home 15:49 Netanyahu is an American 16:49 Netanyahu: Trump is Israel's "great friend" 18:11 Deportations of pro-Palestine students 19:06 IDF prepares to expel Palestinians 19:44 Gaza is an open-air prison 20:55 Bipartisan US imperialism 22:18 Outro

Israel bombards Lebanon, breaching truce deal "Israeli warplanes carried out new violations of a ceasefire agreement with air strikes on southern and eastern Lebanon. Fighter jets targeted an eastern mountain range near the Beqaa Valley, Lebanon's National News Agency (NNA) reported. Two more air strikes hit Nabatiyeh district, striking the valley between Bfaroueh and Aazze. Israeli jets also flew over Beirut and its suburbs, further escalating tensions." Trump's Gaza plan mirrors his son-in-law's waterfront property idea "US President Donald Trump's proposal to take over Gaza and displace Palestinians echoes past comments by his son-in-law Jared Kushner on Gaza's ""waterfront property."" Last year, Kushner suggested Israel should remove Palestinians via the Rafah crossing or Negev Desert while it ""cleans up"" the area. He claimed the enclave's coastline could be valuable with the ""right diplomacy.""" Trump sanctions ICC over arrest warrant against ally Netanyahu "US President Donald Trump signed an executive order imposing sanctions on the International Criminal Court (ICC) over its investigations into the US and Israel. The order accused the ICC of ""abusing its power"" after it issued an arrest warrant for Israeli Prime Minister Benjamin Netanyahu. It includes asset freezes and travel bans on ICC officials and others involved in the court's probes." ‘It is time for peace' in Democratic Republic of Congo: UN chief "UN Secretary-General Antonio Guterres called for peace in the Democratic Republic of Congo, describing the situation as ""deeply concerning."" Speaking in New York, he urged global unity ahead of a summit in Tanzania with East African and South African leaders. The meeting will focus on M23 rebel attacks and ongoing clashes with the Congolese military." Massive asteroid has 1 in 43 chance of colliding with Earth "NASA has raised the odds of asteroid 2024 YR hitting Earth in 2032 to 2.3%, up from 1.3% estimated by the European Space Agency last week. The football field-sized asteroid could release energy equivalent to eight megatons of TNT if it enters Earth's atmosphere. While smaller than the dinosaur-killing asteroid, it would still cause significant destruction."

Today the Chicks chat about Trump's proposal for the Gaza strip, Karoline Leavitt hearing the media like cats, and why AOC and her gang are so upset right now.Stay protected from data breaches and brokers with Aura.  Visit https://Aura.com/Chicks to start your 14-day free trial today.Make thoughtful choices this year.  Visit https://ReadyWise.com and use promo code CHICKS20 at checkout for 20% off your entire purchase. Preparedness is the gift of peace of mind.Go to https://www.OmahaSteaks.com/Chicks to subscribe and get 12 FREE burgers, FREE shipping, and an EXTRA 10% OFF for the life of your subscription. Minimum purchase may apply. A big thanks to our advertiser, Omaha Steaks! 

Claim your complimentary gift of my exclusive mini weight care guide today!Link: Weight Care Guide — Dr. Francavilla Show (thedrfrancavillashow.coWith the recent release of The Lancet's consensus article, the conversation around obesity treatment and care is evolving. To explore the implications of this shift, I'm joined by Dr. Robert Kushner, a respected expert in the field who has dedicated his career to advancing obesity medicine.Dr. Kushner is a professor at Northwestern University Feinberg School of Medicine and the author of over 250 publications and several books on nutrition and obesity. He also co-founded the American Board of Obesity Medicine, contributing to the foundation of obesity care. His latest book, Patient-Centered Weight Management, offers healthcare professionals practical insights. With his extensive experience, Dr. Kushner continues to shape the direction of obesity treatment.In this discussion, we examine the differences between clinical and preclinical obesity and address the important question: should preclinical obesity be treated? Dr. Kushner also explains why a new approach to obesity assessment is essential for the future of healthcare.Be sure to stick around until the end for my takeaways and thoughts on how this impacts healthcare. Want to dive deeper into this discussion? Tune into the full episode and let's unpack it all together!Connect with Dr. Kushner:Website: https://drrobertkushner.com/Connect with me:Instagram: doctorfrancavillaFacebook: Help Your Patients Lose Weight with Dr. FrancavillaWebsite: Dr. Francavilla ShowYoutube: The Doctor Francavilla ShowGLP Strong: glpstrong.com

durée : 01:59:32 - Les Matins du samedi - par : Nicolas Herbeaux - Cette semaine dans les Matins du samedi, on s'intéresse à la Lune, déclarée en danger par la World Monuments Fund, la hausse de la cocaïne en France selon le dernier rapport de l'OFDT et au dernier roman de Rachel Kushner "Le Lac de la Création", aux éditions Stock. - réalisation : Jean-Christophe Francis - invités : Bénédicte de Montlaur Présidente et directrice générale de World Monuments Fund. ; Gladys Lutz Nale Directrice STUPP (Santé Travail Usages de psychotropes et Prévention), docteure en psychosociologie du travail; Guillaume Airagnes Directeur de l'OFDT, Psychiatre et addictologue ; Rachel Kushner Écrivaine

About two years ago, we released a podcast with Dr. Thomas Wadden of the University of Pennsylvania describing work on a new generation of medications to treat diabetes and obesity. They were really taking the field by storm. Since then, much more is known since many additional studies have been published and so many people have been using the drugs. So many, in fact, the market value of the Danish company, Novo Nordisk, one of the two major companies selling the drugs, has gone up. It is now greater than the entire budget of the country of Denmark. This single company is responsible for about half of Denmark's economic expansion this year. So, a lot of people are now taking the drugs and this is a great time for an update on the drugs. And we're fortunate to have two of the world's leading experts join us: Dr. Wadden, Professor of Psychology and Psychiatry at the University of Pennsylvania School of Medicine and the inaugural Albert J. Stunkard Professor of Psychiatry at Penn. Joining us as well as Dr. Robert Kushner, a physician and professor of medicine at Northwestern University and a pioneer in testing treatments for obesity. Interview Summary Tom, you and I were colleagues at Penn decades ago. And I got frustrated the treatments for obesity didn't work very well. People tended to regain the weight. And I turned my attention to prevention and policy. But you hung in there and I admired you for that patience and persistence. And Bob, the same for you. You worked on this tenacious problem for many years. But for both of you, your patience has been rewarded with what seems to me to be a seismic shift in the way obesity and diabetes can be treated. Tom, I'll begin with you. Is this as big of a deal as it seems to me? Well, I think it is as big of a deal as it seems to you. These medications have had a huge impact on improving the treatment of type 2 diabetes, but particularly the management of obesity. With older medications, patients lost about 7 percent of their starting weight. If you weighed 200 pounds, you'd lose about 15 pounds. That was also true of our best diet and exercise programs. You would lose about 7 percent on those programs with rigorous effort. But with the new medications, patients are now losing about 15 to 20 percent of their starting body weight at approximately one year. And that's a 30-to-40-pound loss for a person who started at 200 pounds. And with these larger weight losses, we get larger improvements in health in terms of complications of obesity. So, to quote a good friend of mine, Bob Kushner, these medications have been a real game changer. Thanks for putting that in perspective. I mean, we're talking about not just little incremental changes in what treatments can produce, which is what we've seen for years. But just orders of magnitude of change, which is really nice to see. So, Bob what are these medications that we're talking about? What are the names of the drugs and how do they work? Well, Kelly, this transformation of obesity really came about by finding the target that is really highly effective for obesity. It's called the gut brain axis. And when it comes to the gut it's starting off with a naturally occurring gut hormone called GLP 1. I think everyone in the country's heard of GLP 1. It's released after we eat, and it helps the pancreas produce insulin, slows the stomach release of food, and reduces appetite. And that's where the obesity story comes in. So pharmaceutical companies have taken this hormone and synthesized it, something similar to GLP 1. It mimics the action of GLP 1. So, you could actually take it and give it back and have it injected so it augments or highlights this hormonal effect. Now, that same process of mimicking a hormone is used for another gut hormone called GIP that also reduces appetite. These two hormones are the backbone of the currently available medication. There's two on the market. One is called Semaglutide. That's a GLP 1 analog. Trade name is Wegovy. Now, it's also marketed for diabetes. Tom talked about how it is used for diabetes and increases insulin. That trade name is Ozempic. That's also familiar with everyone around the country. The other one that combined GLP 1 and GIP, these two gut hormones, so it's a dual agonist, the trade name for obesity is called Zep Bound, and the same compound for diabetes is called Mounjaro. These are terms that are becoming familiar, I think, to everyone in the country. Tom mentioned some about the, how much weight people lose on these drugs, but what sort of medical changes occur? Just to reiterate what Tom said, I'll say it in another way. For Semaglutide one third of individuals are losing 20 percent of their body weight in these trials. For Tirzepatide, it even outpaces that. And I got a third of individuals losing a quarter of their body weight. These are unheard of weight losses. And with these weight losses and these independent effects from weight, what we're seeing in the trials and in the clinic is that blood pressure goes down, blood sugar goes down, blood fats like triglyceride go down, inflammation in the body goes down, because we marked that with CRP, as well as improvement in quality of life, which we'll probably get to. But really interesting stuff is coming out over the past year or two or so, that it is improving the function of people living with congestive heart failure, a particular form called a preserved ejection fraction. We're seeing improvements in sleep apnea. Think of all the people who are on these CPAP machines every night. We're seeing significant improvements in the symptoms of sleep apnea and the apneic events. And lastly, a SELECT trial came out, that's what it was called, came out last year. Which for the very first time, Kelly, found improvements in cardiovascular disease, like having a heart attack, stroke, or dying of cardiovascular disease in people living with obesity and already have cardiovascular disease. That's called secondary prevention. That, Tom, is the game changer. Bob, I'd like to go back to Tom in a minute but let me ask you one clarifying question about what you just said. That's a remarkable array of biological medical benefits from these drugs. Just incredible. And the question is, are they all attributable to the weight loss or is there something else going on? Like if somebody lost equal amounts of weight by some other means, would these same changes be occurring? Those studies are still going on. It's very good. We're thinking it's a dual effect. It's the profound amount of weight loss, as Tom said. Fifteen to 21 to even 25 percent of average body weight. That is driving a lot of the benefits. But there also appear to be additional effects or weight independent effects that are working outside of that weight. We're seeing improvements in kidney function, improvement in heart disease, blood clotting, inflammation. And those are likely due to the gut hormone effect independent of the weight itself. That still needs to be sorted out. That's called a mitigation analysis where we try to separate out the effects of these drugs. And that work is still underway. Tom, one of the most vexing problems, over the decades that people have been working on treatments for obesity, has been long term results. And I'm curious about how long have people been followed on these drugs now? What are the results? And what was the picture before then? How do what we see now compared to what you saw before? The study that Bob just mentioned, the SELECT trial followed people for four years on Semaglutide. And patients achieve their maximal weight loss at about one year and they lost 10 percent of their weight. And when they were followed up at four years still on treatment, they still maintained a 10 percent weight loss. That 10 percent is smaller than in most of the trials, where it was a 15 percent loss. But Dr. Tim Garvey showed that his patients in a smaller trial lost about 15 percent at one year and while still on medication kept off the full 15 percent. I think part of the reason the weight loss in SELECT were smaller is because the study enrolled a lot of men. Men are losing less weight on this medication than women. But to your question about how these results compare to the results of earlier treatment, well with behavioral treatment, diet, and exercise back in the 70s beyond, people lost this 7 or 8 percent of weight. And then most people on average regain their weight over one to three years. And the same was true of medication. People often stopped these earlier medications after 6 to 12 months, in part because they're frustrated the losses weren't larger. Some people were also worried about the side effects. But the long and short is once you stop taking the medication, people would tend to regain their weight. And some of this weight regain may be attributable to people returning to their prior eating and activity habits. But one of the things we've learned over the past 20 years is that part of the weight regain seems to be attributable to changes in the body's metabolism. And you know that when you lose weight, you're resting metabolic rate, which is the number of calories your body burns at rest to maintain basic bodily functions. Your resting metabolic rate decreases by 10 to 15 percent. But also, your energy expenditure, the calories you burn during exercise decreases. And that may decrease by as much as 20 to 30 percent. So, people are left having to really watch their calories very carefully because of their lower calorie requirements in order to keep off their lost body weight. I think one thing these new drugs may do is to attenuate the drop both in resting metabolic rate and energy expenditure during physical activity. But the long and short of it is that if you stay on these new medications long term, you'll keep off your body weight. And you'll probably keep it off primarily because of improvements in your appetite, so you have less hunger. And as a result, you're eating less food. I'd like to come back to that in a minute. But let me ask a question. If a person loses weight, and then their body starts putting biological pressure on them to regain, how come? You know, it's disadvantageous for their survival and their health to have the excess weight. Why would the body do that? Well, our bodies evolved in an environment of food scarcity, and our physiology evolved to protect us against starvation. First, by allowing us to store body fat, a source of energy when food is not available. And second, the body's capacity to lower its metabolism, or the rate at which calories are burned to maintain these basic functions like body temperature and heart rate. That provided protection against food scarcity. But Kelly, you have described better than anybody else that these ancient genes that regulate energy expenditure and metabolism are now a terrible mismatch for an environment in which food is plentiful, high in calories, and available 24 by 7. The body evolved to protect us from starvation, but not from eating past our calorie needs. And so, it's this mismatch between our evolution and our appetite and our body regulation in the current, what you have called toxic food environment, when you can eat just all the time. I guess you could think about humans evolving over thousands of years and biology adapting to circumstances where food was uncertain and unpredictable. But this modern environment has happened really pretty rapidly and maybe evolution just hasn't had a chance to catch up. We're still existing with those ancient genes that are disadvantageous in this kind of environment. Bob back to the drugs. What are the side effects of the drugs? Kelly, they're primarily gastrointestinal. These are symptoms like nausea, diarrhea, constipation, heartburn, and vomiting. Not great, but they're generally considered mild to moderate, and temporary. And they primarily occur early during the first four to five months when the medications are slowly dose escalated. And we've learned, most importantly, how to mitigate or reduce those side effects to help people stay on the drug. Examples would be your prescriber would slow the dose escalation. So. if you're having some nausea at a particular dose, we wait another month or two. The other, very importantly, is we have found that diet significantly impacts these side effects. When we counsel patients on these medications, along with that comes recommendations for dietary changes, such as reducing fatty food and greasy food. Reducing the amount of food you're consuming. Planning your meals in advance. Keeping well hydrated. And very importantly, do not go out for a celebration or go out to meals on the day that you inject or at least the first two days. Because you're not going to tolerate the drug very well. We use that therapeutically. So, if you want to get control on the weekends, you may want to take your injection on a Friday. However, if weekends are your time out with friends and you want to socialize, don't take it on a Friday. Same thing comes with a personal trainer, by the way. If you're going to have a personal trainer on a Monday where he's going to overwork you, don't take the injection the day before. You'll likely be nauseated, you're not eating, you're not hydrating. So actually, there's a lot that goes into not only when to take the dose and how to take the dose, but how to take it to the best ability to tolerate it. Two questions based on what you said. One is you talked about these are possible side effects, but how common are they? I mean, how many people suffer from these? Well, the trials show about 25 to 45 percent or so of individuals actually say they have these symptoms. And again, we ask them mild, moderate, severe. Most of them are mild to moderate. Some of them linger. However, they really do peak during the dose escalation. So, working with your prescriber during that period of time closely, keeping contact with them on how to reduce those side effects and how you're doing out of medication is extremely important. And the second thing I wanted to ask related to that is I've heard that there's a rare but serious potential side effect around the issue of stomach paralysis. Can you tell us something about that? I mentioned earlier, Kelly, that these medications slow gastric emptying. That's pretty much in everybody. In some individuals who may be predisposed to this, they develop something called ileus, and that's the medical term for gastric paralysis. And that can happen in individuals, let's say who have a scleroderma, who have longstanding diabetes or other gastrointestinal problems where the stomach really stopped peristalsis. In other words, it's moving. That's typically presented by vomiting and really unable to move the food along. We really haven't seen much of that. We looked at the safety data in a SELECT trial that Tom mentioned, which was 17,000 individuals, about 8,000 or so in each group. We really did not see a significant increase in the ileus or what you're talking about in that patient population. Okay, thanks. Tom had alluded to this before, Bob, but I wanted to ask you. How do you think about these medicines? If somebody takes them, and then they stop using the medicines and they gain the weight back. Is that a sign that the medicine works or doesn't work? And is this the kind of a chronic use drug like you might take for blood pressure or cholesterol? That's a great way of setting up for that. And I like to frame it thinking of it as a chronic progressive disease, just like diabetes or hypertension. We know that when you have those conditions, asthma could be another one or inflammatory bowel disease, where you really take a medication long term to keep the disease or condition under control. And we are currently thinking of obesity as a chronic disease with dysfunctional appetite and fat that is deposited in other organs, causing medical problems and so on. If you think of it as a chronic disease, you would naturally start thinking of it, like others, that medication is used long term. However, obesity appeared to be different. And working with patients, they still have this sense 'that's my fault, I know I can do it, I don't want to be on medication for the rest of my life for this.' So, we have our work cut out for us. One thing I can say from the trials, and Tom knows this because he was involved in them. If we suddenly stop the medication, that's how these trials were definitely done, either blindly or not blindly, you suddenly stop the medication, most, if not all of the participants in these trials start to regain weight. However, in a clinical practice, that is not how we work. We don't stop medication suddenly with patients. We go slowly. We down dose the medication. We may change to another medication. We may use intermittent therapy. So that is work that's currently under development. We don't know exactly how to counsel patients regarding long term use of the medications. I think we need to double down on lifestyle modification and counseling that I'm sure Tom is going to get into. This is really work ahead of us, how to maintain medication, who needs to be on it long term, and how do we actually manage patients. Tom, you're the leading expert in the world on lifestyle change in the context of obesity management. I mean, thinking about what people do with their diet, their physical activity, what kind of thinking they have related to the weight loss. And you talked about that just a moment ago. Why can't one just count on the drugs to do their magic and not have to worry about these things? Well, first, I think you can count on the drugs to do a large part of the magic. And you may be surprised to hear me say that. But with our former behavioral treatments of diet and exercise, we spent a lot of time trying to help people identify how many calories they were consuming. And they did that by recording their food intake either in paper and pencil or with an app. And the whole focus of treatment was trying to help people achieve a 500 calorie a day deficit. That took a lot of work. These medications, just by virtue of turning down your appetite and turning down your responsiveness to the food environment, take away the need for a lot of that work, which is a real blessing. But the question that comes up is, okay, people are eating less food. But what are they eating? Do these medications help you eat a healthier diet with more fruits and vegetables, with lean protein? Do you migrate from a high fat, high sugar diet to a Mediterranean diet, or to a DASH like diet? And the answer is, we don't know. But obviously you would like people to migrate to a diet that's going to be healthier for you from a cardiovascular standpoint, from a cancer risk reduction standpoint. One of the principal things that people need to do on these medications is to make sure they get plenty of protein. And so, guidance is that you should have about 1 gram of dietary protein for every kilogram of body weight. If you're somebody who weighs 100 kilograms, you should get 100 grams of protein. And what you're doing is giving people a lot of dietary protein to prevent the loss of bodily protein during rapid weight loss. You did a [00:20:00] lot of research with me back in the 80s on very low-calorie diets, and that was the underpinning of treatment. Give people a lot of dietary protein, prevent the loss of bodily protein. The other side of the equation is just physical activity, and it's a very good question about whether these medications and the weight loss they induce will help people be more physically active. I think that they will. Nonetheless for most people, you need to plan an activity schedule where you adopt new activities, whether it's walking more or going to the gym. And one thing that could be particularly helpful is strength training, because strength training could mitigate some of the loss of muscle mass, which is likely to occur with these medications. So, there's still plenty to learn about what is the optimal lifestyle program, but I think people, if they want to be at optimal health will increase their physical activity and eat a diet of fruits and vegetables, leaner protein, and less ultra processed foods. Well, isn't it true that eating a healthy diet and being physically active have benefits beyond their impact on your ability to lose the weight? You're getting kind of this wonderful double benefit, aren't you? I believe that is true. I think you're going to find that there are independent benefits of being physical activity upon your cardiovascular health. There are independent benefits of the food that you're eating in terms of reducing the risk of heart attack and of cancer, which has become such a hot topic. So, yes how you exercise and what you eat makes a difference, even if you're losing weight. Well, plus there's probably the triple one, if you will, from the psychological benefit of doing those things, that you do those things, you feel virtuous, that helps you adhere better as you go forward, and these things all come together in a nice picture when they're working. Tom, let's talk more about the psychology of these things. You being a psychologist, you've spent a lot of time doing research on this topic. And of course, you've got a lot of clinical experience with people. So as people are losing weight and using these drugs, what do they experience? And I'm thinking particularly about a study you published recently, and Bob was a coauthor on that study that addressed mental health outcomes. What do people experience and what did you find in that study? I think the first things people experience is improvements in their physical function. That you do find as you've lost weight that you've got less pain in your knees, you've got more energy, it's easier to get up the stairs, it's easier to play with the children or the grandchildren. That goes a long way toward making people feel better in terms of their self-efficacy, their agency in the life. Big, big improvement there. And then, unquestionably, people when they're losing a lot of weight tend to feel better about their appearance in some cases. They're happy that they can buy what they consider to be more fashionable clothes. They get compliments from friends. So, all of those things are positive. I'm not sure that weight loss is going to change your personality per se, or change your temperament, but it is going to give you these physical benefits and some psychological benefits with it. We were happy to find in the study you mentioned that was conducted with Bob that when people are taking these medications, they don't appear to be at an increased risk of developing symptoms of depression or symptoms of suicidal ideation. There were some initial reports of concern about that, but the analysis of the randomized trials that we conducted on Semaglutide show that there is no greater likelihood of developing depression or sadness or suicidal ideation on the medication versus the placebo. And then the FDA and the European Medicines Agency have done a full review of all post marketing reports. So, reports coming from doctors and the experience with their patients. And in looking at those data the FDA and the European Medicines Agency have said, we don't find a causal link between these medications and suicidal ideation. With that said, it's still important that if you're somebody who's taking these medications and you start them, and all of a sudden you do feel depressed, or all of a sudden you do have thoughts like, maybe I'd be better off if I weren't alive any longer, you need to talk to your primary care doctor immediately. Because it is always possible somebody's having an idiosyncratic reaction to these medications. It's just as possible the person would have that reaction without being on a medication. You know, that, that can happen. People with overweight and obesity are at higher risk of depression and anxiety disorders. So, it's always going to be hard to tease apart what are the effects of a new medication versus what are just the effects of weight, excess weight, on your mood and wellbeing. You know, you made me think of something as you were just speaking. Some people may experience negative effects during weight loss, but overall, the effects are highly positive and people are feeling good about themselves. They're able to do more things. They fit in better clothes. They're getting good feedback from their environment and people they know. And then, of course, there's all the medical benefit that makes people feel better, both psychologically and physically. Yet there's still such a strong tendency for people to regain weight after they've lost. And it just reinforces the fact that, the point that you made earlier, that there are biological processes at work that govern weight and tendency to regain. And there really is no shame in taking the drug. I mean, if you have high blood pressure, there's no shame in taking the drug. Or high cholesterol or anything else, because there's a biological process going on that puts you at risk. The same thing occurs here, so I hope the de-shaming, obesity in the first place, and diabetes, of course, and then the use of these medications in particular might help more people get the benefits that is available for them. I recommend that people think about their weight as a biologically regulated event. Very much like your body temperature is a biologically regulated event, as is your blood pressure and your heart rate. And I will ask people to realize that there are genetic contributors to your body weight. just as there are to your height. If somebody says, I just feel so bad about being overweight I'll just talk with them about their family history of weight and see that it runs in the family. Then I'll talk to them about their height. Do you feel bad about being six feet tall, to a male? No, that's fine. Well, that that's not based upon your willpower. That's based upon your genes, which you received. And so, your weight, it's similarly based. And if we can use medications to help control weight, cholesterol, blood pressure, blood sugar, let's do that. It's just we live in a time where we're fortunate to have the ability to add medications to help people control health complications including weight. Bob, there are several of the drugs available. How does one think about picking between them? Well, you know, in an ideal medical encounter, the prescriber is going to take into consideration all the factors of prescribing a medication, like any other medication, diabetes, hypertension, you name the condition. Those are things like contraindication to use. What other medical problems does the patient have that may benefit the patient. Patient preferences, of course and side effects, safety, allergies, and then we have cost. And I'll tell you, Kelly, because of our current environment, it's this last factor, cost, that's the most dominant factor when it comes to prescribing medication. I'll have a patient walk in my room, I'll look at the electronic medical record, body mass index, medical problems. I already know in my head what is going to be the most effective medication. That's what we're talking about today. Unfortunately, I then look at the patient insurance, which is also on the electronic medical record, and I see something like Medicaid or Medicare. I already know that it's not going to be covered. It is really quite unfortunate but ideally all these factors go into consideration. Patients often come in and say, I've heard about Ozempic am I a candidate for it, when can I get it? And unfortunately, it's not that simple, of course. And those are types of decisions the prescriber goes through in order to come to a decision, called shared decision making with the patient. Bob, when I asked you the initial question about these drugs, you were mentioning the trade name drugs like Mounjaro and Ozempic and those are made by basically two big pharmaceutical companies, Novo Nordisk and Eli Lilly. But there are compounded versions of these that have hit the scene. Can you explain what that means and what are your thoughts about the use of those medications? So compounding is actually pretty commonly done. It's been approved by the FDA for quite some time. I think most people are familiar with the idea of compounding pharmacies when you have a child that must take a tablet in a liquid form. The pharmacy may compound it to adapt to the child. Or you have an allergy to an ingredient so the pharmacy will compound that same active ingredient so you can take it safely. It's been approved for long periods of time. Anytime a drug is deemed in shortage by the FDA, but in high need by the public, compounding of that trade drug is allowed. And that's exactly what happened with both Semaglutide and Tirzepatide. And of course, that led to this compounding frenzy across the country with telehealth partnering up with different compounding pharmacies. It's basically making this active ingredient. They get a recipe elsewhere, they don't get it from the company, they get this recipe and then they make the drug or compound it themselves, and then they can sell it at a lower cost. I think it's been helpful for people to get the drug at a lower cost. However, buyer beware, because not all compounded pharmacies are the same. The FDA does not closely regulate these compounded pharmacies regarding quality assurance, best practice, and so forth. You have to know where that drug is coming from. Kelly, it's worth noting that just last week, ZepBound and Mounjaro came off the shortage list. You no longer can compound that and I just read in the New York Times today or yesterday that the industry that supports compounding pharmacies is suing the FDA to allow them to continue to compound it. I'm not sure where that's going to go. I mean, Eli Lilly has made this drug. However, Wegovy still is in shortage and that one is still allowed to be compounded. Let's talk a little bit more about costs because this is such a big determinant of whether people use the drugs or not. Bob, you mentioned the high cost, but Tom, how much do the drugs cost and is there any way of predicting what Bob just mentioned with the FDA? If the compounded versions can't be used because there's no longer a shortage, will that decrease pressure on the companies to keep the main drug less expensive. I mean, how do you think that'll all work out? But I guess my main question is how much these things cost and what's covered by insurance? Well first how much do the drugs cost? They cost too much. Semaglutide, known in retail as Wegovy, is $1,300 a month if you do not have insurance that covers it. I believe that Tirzepatide, known as ZepBound, is about $1,000 a month if you don't have insurance that covers that. Both these drugs sometimes have coupons that bring the price down. But still, if you're going to be looking at out of pocket costs of $600 or $700 or $800 a month. Very few people can afford that. The people who most need these medications are people often who are coming from lower incomes. So, in terms of just the future of having these medications be affordable to people, I would hope we're going to see that insurance companies are going to cover them more frequently. I'm really waiting to see if Medicare is going to set the example and say, yes, we will cover these medications for anybody with a BMI of 40 or a BMI of 35 with comorbidities. At this point, Medicare says, we will only pay for this drug if you have a history of heart attack and stroke, because we know the drug is going to improve your life expectancy. But if you don't have that history, you don't qualify. I hope we'll see that. Medicaid actually does cover these medications in some states. It's a state-by-state variation. Short of that, I think we're going to have to have studies showing that people are on these medications for a long time, I mean, three to five years probably will be the window, that they do have a reduction in the expenses for other health expenditures. And as a result, insurers will see, yes, it makes sense to treat excess weight because I can save on the cost of type 2 diabetes or sleep apnea and the like. Some early studies I think that you brought to my attention say the drugs are not cost neutral in the short-term basis of one to two years. I think you're going to have to look longer term. Then I think that there should be competition in the marketplace. As more drugs come online, the drug prices should come down because more will be available. There'll be greater production. Semaglutide, the first drug was $1,300. Zepbound, the second drug Tirzepatide, $1,000. Maybe the third drug will be $800. Maybe the fourth will be $500. And they'll put pressure on each other. But I don't know that to be a fact. That's just my hope. Neither of you as an economist or, nor do you work with the companies that we're talking about. But you mentioned that the high cost puts them out of reach for almost everybody. Why does it make sense for the companies to charge so much then? I mean, wouldn't it make sense to cut the price in half or by two thirds? And then so many more people would use them that the company would up ahead in the long run. Explain that to me. That's what you would think, for sure. And I think that what's happened right now is that is a shortage of these drugs. They cannot produce enough of them. Part of that is the manufacturing of the injector pens that are used to dispense the drug to yourself. I know that Novo Nordisk is building more factories to address this. I assume that Lilly will do the same thing. I hope that over time we will have a larger supply that will allow more people to get on the medication and I hope that the price would come down. Of course, in the U. S. we pay the highest drug prices in the world. Fortunately, given some of the legislation passed, Medicare will be able to negotiate the prices of some of these drugs now. And I think they will negotiate on these drugs, and that would bring prices down across the board. Boy, you know, the companies have to make some pretty interesting decisions, don't they? Because you've alluded to the fact that there are new drugs coming down the road. I'm assuming some of those might be developed and made by companies other than the two that we're talking about. So, so investing in a whole new plant to make more of these things when you've got these competitor drugs coming down the road are some interesting business issues. And that's not really the topic of what we're going to talk about, but it leads to my final question that I wanted to ask both of you. What do you think the future will bring? And what do you see in terms of the pipeline? What will people be doing a year from now or 2 or 5? And, you know, it's hard to have a crystal ball with this, but you two have been, you know, really pioneers and experts on this for many years. You better than anybody probably can answer this question. Bob, let me start with you. What do you think the future will bring? Well, Kelly, I previously mentioned that we finally have this new therapeutic target called the gut brain axis that we didn't know about. And that has really ushered in a whole new range of potential medications. And we're really only at the beginning of this transformation. So not only do we have this GLP 1 and GIP, we have other gut hormones that are also effective not only for weight loss, but other beneficial effects in the body, which will become household names, probably called amylin and glucagon that joins GLP 1. And we not only have these monotherapies like GLP 1 alone, we are now getting triagonists. So, we've got GIP, GLP 1, and glucagon together, which is even amplifying the effect even further. We are also developing oral forms of GLP 1 that in the future you could presumably take a tablet once a day, which will also help bring the cost down significantly and make it more available for individuals. We also have a new generation of medications being developed which is muscle sparing. Tom talked about the importance of being strong and physical function. And with the loss of lean body mass, which occurs with any time you lose weight, you can also lose muscle mass. There's drugs that are also going in that direction. But lastly, let me mention, Kelly, I spend a lot of my time in education. I think the exciting breakthroughs will not be meaningful to the patient unless the professional, the provider and the patient are able to have a nonjudgmental informative discussion during the encounter without stigma, without bias. Talk about the continuum of care available for you, someone living with obesity, and get the medications to the patient. Without that, medications over really sit on the shelf. And we have a lot of more work to do in that area. You know, among the many reasons I admire the both of you is that you've, you've paid a lot of attention to that issue that you just mentioned. You know, what it's like to live with obesity and what people are experiencing and how the stigma and the discrimination can just have devastating consequences. The fact that you're sensitive to those issues and that you're pushing to de-stigmatize these conditions among the general public, but also health care professionals, is really going to be a valuable advance. Thank you for that sensitivity. Tom, what do you think? If you appear into the crystal ball? What does it look like? I would have to agree with Bob that we're going to have so many different medications that we will be able to combine together that we're going to see that it's more than possible to achieve weight losses of 25 to 30 percent of initial body weight. Which is just astonishing to think that pharmaceuticals will be able to achieve what you achieve now with bariatric surgery. I think that it's just, just an extraordinary development. Just so pleased to be able to participate in the development of these drugs at this stage of career. I still see a concern, though, about the stigmatization of weight loss medications. I think we're going to need an enormous dose of medical education to help doctors realize that obesity is a disease. It's a different disease than some of the illnesses that you treat because, yes, it is so influenced by the environment. And if we could change the environment, as you've argued so eloquently, we could control a lot of the cases of overweight and obesity. But we've been unable to control the environment. Now we're taking a course that we have medications to control it. And so, let's use those medications just as we use medications to treat diabetes. We could control diabetes if the food environment was better. A lot of medical education to get doctors on board to say, yes, this is a disease that deserves to be treated with medication they will share that with their patients. They will reassure their patients that the drugs are safe. And that they're going to be safe long term for you to take. And then I hope that society as a whole will pick up that message that, yes, obesity and overweight are diseases that deserve to be treated the same way we treat other chronic illnesses. That's a tall order, but I think we're moving in that direction. BIOS Robert Kushner is Professor of Medicine and Medical Education at Northwestern University Feinberg School of Medicine, and Director of the Center for Lifestyle Medicine in Chicago, IL, USA. After finishing a residency in Internal Medicine at Northwestern University, he went on to complete a post-graduate fellowship in Clinical Nutrition and earned a Master's degree in Clinical Nutrition and Nutritional Biology from the University of Chicago. Dr. Kushner is past-President of The Obesity Society (TOS), the American Society for Parenteral and Enteral Nutrition (ASPEN), the American Board of Physician Nutrition Specialists (ABPNS), past-Chair of the American Board of Obesity Medicine (ABOM), and Co-Editor of Current Obesity Reports. He was awarded the ‘2016 Clinician-of-the-Year Award' by The Obesity Society and John X. Thomas Best Teachers of Feinberg Award at Northwestern University Feinberg School of Medicine in 2017. Dr. Kushner has authored over 250 original articles, reviews, books and book chapters covering medical nutrition, medical nutrition education, and obesity, and is an internationally recognized expert on the care of patients who are overweight or obese. He is author/editor of multiple books including Dr. Kushner's Personality Type Diet (St. Martin's Griffin Press, 2003; iuniverse, 2008), Fitness Unleashed (Three Rivers Press, 2006), Counseling Overweight Adults: The Lifestyle Patterns Approach and Tool Kit (Academy of Nutrition and Dietetics, 2009) and editor of the American Medical Association's (AMA) Assessment and Management of Adult Obesity: A Primer for Physicians (2003). Current books include Practical Manual of Clinical Obesity (Wiley-Blackwell, 2013), Treatment of the Obese Patient, 2nd Edition (Springer, 2014), Nutrition and Bariatric Surgery (CRC Press, 2015), Lifestyle Medicine: A Manual for Clinical Practice (Springer, 2016), and Obesity Medicine, Medical Clinics of North America (Elsevier, 2018). He is author of the upcoming book, Six Factors to Fit: Weight Loss that Works for You! (Academy of Nutrition and Dietetics, December, 2019). Thomas A. Wadden is a clinical psychologist and educator who is known for his research on the treatment of obesity by methods that include lifestyle modification, pharmacotherapy, and bariatric surgery. He is the Albert J. Stunkard Professor of Psychology in Psychiatry at the Perelman School of Medicine at the University of Pennsylvania and former director of the university's Center for Weight and Eating Disorders. He also is visiting professor of psychology at Haverford College. Wadden has published more than 550 peer-reviewed scientific papers and abstracts, as well as 7 edited books. Over the course of his career, he has served on expert panels for the National Institutes of Health, the Federal Trade Commission, the Department of Veterans Affairs, and the U.S. House of Representatives. His research has been recognized by awards from several organizations including the Association for the Advancement of Behavior Therapy and The Obesity Society. Wadden is a fellow of the Academy of Behavioral Medicine Research, the College of Physicians of Philadelphia, the Obesity Society, and Society of Behavioral Medicine. In 2015, the Obesity Society created the Thomas A. Wadden Award for Distinguished Mentorship, recognizing his education of scientists and practitioners in the field of obesity.

Invest Like the Best: Read the notes at at podcastnotes.org. Don't forget to subscribe for free to our newsletter, the top 10 ideas of the week, every Monday --------- My guest today is Jared Kushner. Jared has lived more lives than just about anyone I know his age. He ran Kushner companies for years, investing in real estate in and around New York City. He owned the New York Observer. He was a senior advisor to President Trump in his first term. He now runs Affinity Partners, which we discuss in detail, a private equity firm built to find and execute unique investments around the world that stem from Jared's unique set of experiences in business and government. This is one of our longest episodes ever because there was so much to discuss. We cover real estate, negotiation, geopolitics, his work in prison reform, Operation Warp Speed, and the Abraham Accords in the Middle East, business, investing, his family, and everything in between. Jared told me I could ask him about anything--and I really enjoyed doing so. Please enjoy my conversation with Jared Kushner. My guests today For the full show notes, transcript, and links to mentioned content, check out the episode page here. ----- This episode is brought to you by Alphasense. AlphaSense has completely transformed the research process with cutting-edge AI technology and a vast collection of top-tier, reliable business content. Imagine completing your research five to ten times faster with search that delivers the most relevant results, helping you make high-conviction decisions with confidence. AlphaSense provides access to over 300 million premium documents, including company filings, earnings reports, press releases, and more from public and private companies. Invest Like the Best listeners can get a free trial now at Alpha-Sense.com/Invest and experience firsthand how AlphaSense and Tegus help you make smarter decisions faster. –- This episode is brought to you by Ridgeline. Ridgeline has built a complete, real-time, modern operating system for investment managers. It handles trading, portfolio management, compliance, customer reporting, and much more through an all-in-one real-time cloud platform. I think this platform will become the standard for investment managers, and if you run an investing firm, I highly recommend you find time to speak with them. Head to ridgelineapps.com to learn more about the platform. –- This episode is brought to you by Ramp. Ramp's mission is to help companies manage their spend in a way that reduces expenses and frees up time for teams to work on more valuable projects. Ramp is the fastest growing FinTech company in history and it's backed by more of my favorite past guests (at least 16 of them!) than probably any other company I'm aware of. Go to Ramp.com/invest to sign up for free and get a $250 welcome bonus. ----- Editing and post-production work for this episode was provided by The Podcast Consultant (https://thepodcastconsultant.com). Show Notes: (00:00:00) Welcome to Invest Like the Best (00:08:45) Jared's Philosophy on Challenges and Success (00:13:38) Real Estate Ventures: The 666 Fifth Avenue Story (00:20:31) Lessons from New York Real Estate (00:30:04) Diplomacy and the Middle East (00:37:03) Leadership and Change (00:41:14) Geopolitical Landscape and Future Prospects (00:47:53) Affinity Partners: Vision and Strategy (00:52:42) Navigating Market Shifts (00:54:39) Case Study: Mexico Investment (00:58:34) Global Investment Strategies (01:02:42) Investment Philosophy and Principles (01:07:04) Challenges and Problem-Solving (01:23:14) Government Efficiency and Bureaucracy (01:34:57) Stepping into the Spotlight (01:37:19) Manifesting Success with Partners (01:38:05) Learning from Brad Jacobs (01:42:09) Middle East Economic Development (01:46:08) The Qatar-Saudi Reconciliation (01:52:25) Perceptions of Key Middle Eastern Countries (02:07:34) Preparing for Trump's Return (02:14:36) Early Days of Thrive Capital (02:16:56) Helping Entrepreneurs and Building Thrive (02:24:51) Lessons from My Father (02:37:47) Future Vision and AI (02:48:45) The Kindest Thing Anyone Has Ever Done For Jared

Our guest is Rachel Kushner. Her writing includes novels like The Mars Room and The Flamethrowers, and essays on everything from prison abolition to art theory and motorcycle racing. Her fourth novel, Creation Lake, is Kushner's take on noir. It follows a young woman infiltrating a French anarchist collective. On December 12th, 2024, Kushner came to the Sydney Goldstein Theater in San Francisco to talk to Jonah Wiener, a culture journalist and contributing writer at the New York Times Magazine. The conversation was wide-ranging, from her research process, to her travels in France, and her opinions on the Tesla Cybertruck. 

My guest today is Jared Kushner. Jared has lived more lives than just about anyone I know his age. He ran Kushner companies for years, investing in real estate in and around New York City. He owned the New York Observer. He was a senior advisor to President Trump in his first term. He now runs Affinity Partners, which we discuss in detail, a private equity firm built to find and execute unique investments around the world that stem from Jared's unique set of experiences in business and government. This is one of our longest episodes ever because there was so much to discuss. We cover real estate, negotiation, geopolitics, his work in prison reform, Operation Warp Speed, and the Abraham Accords in the Middle East, business, investing, his family, and everything in between. Jared told me I could ask him about anything--and I really enjoyed doing so. Please enjoy my conversation with Jared Kushner. My guests today For the full show notes, transcript, and links to mentioned content, check out the episode page here. ----- This episode is brought to you by Alphasense. AlphaSense has completely transformed the research process with cutting-edge AI technology and a vast collection of top-tier, reliable business content. Imagine completing your research five to ten times faster with search that delivers the most relevant results, helping you make high-conviction decisions with confidence. AlphaSense provides access to over 300 million premium documents, including company filings, earnings reports, press releases, and more from public and private companies. Invest Like the Best listeners can get a free trial now at Alpha-Sense.com/Invest and experience firsthand how AlphaSense and Tegus help you make smarter decisions faster. –- This episode is brought to you by Ridgeline. Ridgeline has built a complete, real-time, modern operating system for investment managers. It handles trading, portfolio management, compliance, customer reporting, and much more through an all-in-one real-time cloud platform. I think this platform will become the standard for investment managers, and if you run an investing firm, I highly recommend you find time to speak with them. Head to ridgelineapps.com to learn more about the platform. –- This episode is brought to you by Ramp. Ramp's mission is to help companies manage their spend in a way that reduces expenses and frees up time for teams to work on more valuable projects. Ramp is the fastest growing FinTech company in history and it's backed by more of my favorite past guests (at least 16 of them!) than probably any other company I'm aware of. Go to Ramp.com/invest to sign up for free and get a $250 welcome bonus. ----- Editing and post-production work for this episode was provided by The Podcast Consultant (https://thepodcastconsultant.com). Show Notes: (00:00:00) Welcome to Invest Like the Best (00:08:45) Jared's Philosophy on Challenges and Success (00:13:38) Real Estate Ventures: The 666 Fifth Avenue Story (00:20:31) Lessons from New York Real Estate (00:30:04) Diplomacy and the Middle East (00:37:03) Leadership and Change (00:41:14) Geopolitical Landscape and Future Prospects (00:47:53) Affinity Partners: Vision and Strategy (00:52:42) Navigating Market Shifts (00:54:39) Case Study: Mexico Investment (00:58:34) Global Investment Strategies (01:02:42) Investment Philosophy and Principles (01:07:04) Challenges and Problem-Solving (01:23:14) Government Efficiency and Bureaucracy (01:34:57) Stepping into the Spotlight (01:37:19) Manifesting Success with Partners (01:38:05) Learning from Brad Jacobs (01:42:09) Middle East Economic Development (01:46:08) The Qatar-Saudi Reconciliation (01:52:25) Perceptions of Key Middle Eastern Countries (02:07:34) Preparing for Trump's Return (02:14:36) Early Days of Thrive Capital (02:16:56) Helping Entrepreneurs and Building Thrive (02:24:51) Lessons from My Father (02:37:47) Future Vision and AI (02:48:45) The Kindest Thing Anyone Has Ever Done For Jared

[SEGMENT 1-1] Silly Leftists 1   Welcome, folks. It's KJ Radio time…the show where common sense kicks the buttocks of Leftism. WITH steel-toed boots. And trust me, there's no shortage of targets. UnitedHealthcare CEO Gets ShotFirst up, the CEO of UnitedHealthcare got shot. Now, I'm not saying this guy was involved in something shady, but if you look up “suspicious deaths” in the corporate dictionary, his picture probably pops up next to “knew too much.” A random act of violence? Yeah, and I'm the Easter Bunny. I mean, who gets shot at 3 PM on a Tuesday unless they're either a mob boss or a whistleblower? Somewhere in a boardroom, some healthcare exec just said, “See? THIS is why we stick to overcharging customers—it's safer!” SCOTUS and the Transgender CircusOver at the Supreme Court, we've got the transgender issue. And let me tell you, it's a bloodbath for the Left. Watching Justice Thomas and Alito dismantle the ACLU attorney was like watching Tyson in his prime—just brutal. Meanwhile, Ketanji Brown-Jackson is over here proving once again she couldn't win a game of “Guess Who?” She's supposed to rule on human rights but doesn't know the difference between a man and a woman? What's her benchmark—pronouns on a Starbucks cup? And the ACLU arguing this case? Their strategy is basically, “Well, Your Honor, we think biology is mean.” Pro tip: when you're trying to overturn centuries of reality, you might want to come with something stronger than feelings. Daniel Penny: Subway Defender ExtraordinaireLet's talk Daniel Penny. The man subdued a crazed subway lunatic threatening passengers, and now he's the one facing charges. Meanwhile, New York is releasing criminals like it's a Black Friday sale at Rikers. I say let the guy get back to his life. The only crime here is that we don't have a Daniel Penny on every subway train. The Great Pardon PanicOh, the pardons! Leftists are scrambling like chickens in a fox den. Remember when they lost their collective minds thinking Trump might preemptively pardon his kids? They were frothing at the mouth like rabid dogs, screaming, “Only the guilty need pardons!” Fast forward, and Joe Biden actually pardons Hunter, and suddenly it's a heartwarming story of fatherly love. You've gotta admire the consistency—oh wait, they don't have any.  [SEGMENT 1-2] Silly Leftists 2 And now Biden's gearing up for mass pardons. Rumor has it Adam Schiff's already practicing his “thank you” speech. Fauci's probably prepping too—he'll need one for every agency under his control: the NIH, FDA, CDC. By the time Biden's done, he'll need a bulk discount on “Pardon Me” cards. Trump's Appointments and the Lawsuit ShowdownSpeaking of accountability, let's talk about Trump's appointees. Despite the Left's best smear campaigns, they're holding strong. And Kash Patel threatening to sue Pence's advisor? I LOVE it. Finally, conservatives are playing offense. I don't know about you, but I'm tired of watching Republicans act like it's a three-legged sack race while the Left is in a tank. Let's start suing these clowns into oblivion. Why Be a Democrat Today?Which brings me to this question: why would anyone want to be a Democrat today? What's the appeal? The policies don't work, their scandals are more predictable than Hallmark movies, and their leaders are walking punchlines. Your flagship legislation is “Men Can Have Babies,” your economic policy is “Spend Until Collapse,” and your presidential frontrunner is... Joe Biden? Imagine being on a sinking ship, grabbing a bucket, and saying, “This is fine.” That's the Democratic Party right now. SCOTUS SmackdownBack to the SCOTUS hearing—seriously, the level of delusion on the Left is staggering. They want “special rights” for a mental disorder. And yes, that's what gender dysphoria is. They're trying to legalize feelings. What's next? Mandating that everyone applaud when a grown man in a tutu demands to use the women's restroom?  [SEGMENT 1-3] Silly Leftists 3   [X] SB – Charlamagne on The View Pt 1 The week's insanity has been one big reminder: the Left's hypocrisy knows no bounds. Whether it's defending pardons for their criminals, championing “rights” that defy logic, or spinning corporate corruption into a soap opera, they've mastered the art of ridiculousness. But don't worry, folks—common sense isn't dead. It's just taking a coffee break. [X] SB - Charlamagne on The View Pt 2 Sick of watching everybody else get over?     Pardons, Power, and Protecting the Crooked: Biden's Legacy of Legal Abuse Article II, Section 2 of the Constitution grants the president the authority to pardon offenses against the United States, a power intended to provide fairness and avoid prosecutorial abuses. Alexander Hamilton envisioned this clemency as a tool to “restore the tranquility of the commonwealth.” But in the hands of Joe Biden, the pardon power looks less like a tool for justice and more like a sledgehammer wielded to shield a crumbling empire of corruption. Biden's recent pardon of his son Hunter has spotlighted the blatant hypocrisy of the Left's use of clemency. After years of moral grandstanding, claiming the high road on justice and accountability, Democrats are now orchestrating mass pardons to shield themselves from the fallout of their own malfeasance. Pardons as Preemptive Damage Control During Trump's presidency, Democrats practically dared him to issue preemptive pardons for his family, projecting their own propensity for guilt on the former president. When Trump pardoned Jared Kushner's father, the media spun it as though he had pardoned Kushner himself. That narrative stuck, fueling the perception of Trump as corrupt, even as his actual record on pardons tells a different story. Trump, notably, did not pardon his children or any close associates preemptively. Why? Because they weren't guilty of anything. Contrast that with Biden, whose pardons aren't just reactive—they're preemptive damage control for an administration rife with misconduct. Leaks suggest Biden is preparing pardons for a laundry list of allies, including Adam Schiff, Liz Cheney, Anthony Fauci, and members of the January 6th Committee. These aren't minor players; they are key figures in the systemic abuse of power targeting Donald Trump and his supporters. The January 6th Committee alone violated so many laws it could be a semester-long case study at any law school. Then there's Fauci. A pardon for Fauci essentially extends to the entire health bureaucracy—NIH, FDA, CDC—that oversaw the disastrous COVID-19 policies. Lockdowns, vaccine mandates, suppression of dissent, and the mishandling of public trust—it's no wonder Biden would want to sweep this under the rug. A Record-Breaking Abuse of Power[SEGMENT 1-4] Silly Leftists 4   Historically, presidents have used pardons sparingly, often to right specific wrongs. Franklin D. Roosevelt holds the record with 2,819 pardons and 3,796 total acts of clemency, largely for people convicted under Prohibition laws. Barack Obama granted 1,927 acts of clemency, including a controversial commutation for Chelsea Manning. But Biden's pardon spree could make FDR's record look modest. Biden's administration isn't dealing with isolated cases of injustice—it's mopping up the collateral damage from years of systemic corruption. Consider the scope:The FBI: With over 37,000 employees, including 10,000 special agents, the agency's involvement in targeting Trump and MAGA supporters is well-documented.The CIA and NSA: These agencies, with a combined workforce exceeding 50,000, played their parts in surveillance and misinformation campaigns.IRS and FISA Courts: From targeting conservative groups to enabling dubious investigations, their roles can't be ignored.Biden's pardons could easily extend to thousands of individuals across these institutions, creating a tsunami of public outrage. This isn't about restoring tranquility; it's about cementing a legacy of corruption while protecting a broken system. Democrats: Masters of Projection The hypocrisy is staggering. Democrats who lambasted Trump for imagined abuses of power are now actively orchestrating the largest clemency cover-up in history. When Joy Reid and Adam Schiff criticized the idea of preemptive pardons, they framed it as an admission of guilt. Yet here we are, watching Biden prepare to issue blanket pardons to his political allies without a shred of irony.   [X] SB – Joy Reid and Adam Schiff on preemptive pardon   Dishonest man… Heard of an innocent person getting a blanket pardon       Hunter Biden's pardon set the tone: a sweeping, decade-long absolution for crimes ranging from tax evasion to illegal firearm possession. The message? Rules are for the little people. Trump: A Study in Contrast Trump's approach to pardons highlights the glaring differences between the two administrations. While Biden's pardons shield the guilty, Trump's were measured and purposeful. Trump used his clemency power to address specific injustices, such as Alice Johnson's over-sentencing or the persecution of Michael Flynn. More importantly, Trump didn't shield himself or his family. His restraint underscores the integrity of his administration compared to the flagrant abuses we're witnessing now. Rebuilding Trust in Justice Biden's pardon spree will leave a lasting stain on America's institutions. But it also presents an opportunity for renewal. When Trump returns to office, he will face the monumental Become a supporter of this podcast: https://www.spreaker.com/podcast/the-kevin-jackson-show--2896352/support.

This week, Axe and Heilemann are joined by former New Jersey Governor Chris Christie! The Hacks dive into Christie's unique insights as Donald Trump's former Transition Team Chairman to explore what a second Trump term might look like: which cabinet picks are likely to stick, and which ones are simply Trump's way of flipping the bird. Plus, the guys unpack the Hunter Biden pardon drama and ask Christie for his thoughts on the Kushner ambassadorship—an ironic twist, given their history.

Jen Psaki explains why the news of President Joe Biden pardoning his son Hunter should not distract you from the people who pose actual threats to our country's national security - like Donald Trump's top cabinet picks. Among them, Pete Hegseth was the subject of a jaw-dropping exposé in the New Yorker, revealing that he was often intoxicated on the job in his early career. Gregg Nunziata and Noah Bookbinder join Jen to discuss the importance of thorough FBI background checks in the confirmation process, from their experience as counsels to the Senate Judiciary Committee. Next, Senator Alex Padilla joins the show to discuss his concerns about Trump's picks for top administration roles and the importance of "restoring norms" to protect our democracy. Jen is also joined by Former Romney Campaign Advisor Kevin Madden and NBC Capitol Hill Correspondent Ali Vitali to discuss what behind-the-scenes considerations might look like on Capitol Hill as Trump's cabinet picks meet with Senators. Later, following Trump's nomination of Charles Kushner to serve as Ambassador to France, Jen breaks down Kushner's "loathsome" criminal history and why it should be disqualifying. Finally, Jen is joined by Minnesota Democratic-Farmer-Labor Party Chairman Ken Martin to discuss why he decided to join the race for DNC chair. Check out our social pages below:https://twitter.com/InsideWithPsakihttps://www.instagram.com/InsideWithPsaki/https://www.tiktok.com/@insidewithpsakihttps://www.msnbc.com/jen-psaki

(2:00) Well, Excuse ME! - The Corrupt Pardons of Both Biden and TrumpBiden (who tells us he never lies) lied about pardoning Hunter; pretends the DOJ is weaponized AGAINST him (but it's weaponized FOR him and for Hunter)Why did Biden stretch the pardon to an entire decade?  Why start with 2014?(15:54) Will Trump Renege on J6 Pardons?Trump's silence on J6 pardons — Hunter's pardon however, is GOOD NEWS for J6ersCowboys for Trump founder says "J6 was the greatest ENTRAPMENT in American history" — and it wasn't BidenWill Pam Bondi stop J6 pardons?Trump pardoned Jared Kushner's father, now appoints as Ambassador to FranceWhy was Jared's father's crimes described as "one of the most loathsome, disgusting crimes I prosecuted"?FOX & MAGA-Media gloss over the crimes, referring to them only as "witness tampering"Trump appoints another in-law (besides Kushner).  It's a Mafia Family(40:42) Trump's Con Man for CommerceTrump's Commerce Secretary — "Lucky" Lutnick and his history of Wall Street Scams like SPACs.  Why do the financial snakes always get Commerce Secretary under Trump?(58:58) LIVE comments - Pam Bondi, literal Drug War against cartels, SPACs, and more (1:11:59) What Happens When LOCAL Law Enforcement Goes Bad?The Sheriff who called in his deputies over a burger that wasn't done HIS wayProsecutor and police lab LIED and this man served DECADES in jail for a crime he did NOT commit(1:31:28) Hanging Chad — Conservatives Go After Trump's DEA Appointment One of the worst COVID tyrants and cheerleader for Vax & LGBT has been selected by Trump to head DEA.  Here's why Chad Chronister is the PERFECT pick (and why conservatives shouldn't be surprised) (58:58) LIVE comments - and our producers (1:56:51) NATO's War — And a NEW Arms RaceBiden loads up Ukraine with weaponsRussian warnings about how quickly their hypersonic missiles (for which there's NO defense) could strike Europe.  Now they show the vulnerability of US targets in Middle East AND AmericaPentagon says it will repurpose their ludicrous "Littoral Combat Ship" (the failed Zumwalt class) to fire hypersonic missiles (that they won't have for 3 or more years) because the original gun was too expensive to fire.  Why would THAT stop the Pentagon?France "removes ALL red lines" in war with RussiaNATO refuses to face reality — tells businesses to prepare for "wartime scenario"The new Arms Race(58:58) LIVE comments - munitions being emptied, Russia & Ukraine Shanghai men to fight, the meat grinder as the fight for "line of contact" escalates — and more producers (2:38:09) Why Being Grateful is Vital — Make America Grateful AgainTrump & Musk celebrate Thanksgiving at Mar-a-Lago — be grateful that you've NOT fallen into the snare that entraps themTo WHOM should we be grateful?Sales of Bibles are booming — why?Ontario town fined $10,000 for not worshipping LGBT during "Pride Month"Euthanasia — most Americans favor it, UK Parliament just passed itWhat does "pro-life" REALLY mean?If you would like to support the show and our family please consider subscribing monthly here: SubscribeStar https://www.subscribestar.com/the-david-knight-show Or you can send a donation throughMail: David Knight POB 994 Kodak, TN 37764Zelle: @DavidKnightShow@protonmail.comCash App at: $davidknightshowBTC to: bc1qkuec29hkuye4xse9unh7nptvu3y9qmv24vanh7 Money should have intrinsic value AND transactional privacy: Go to DavidKnight.gold for great deals on physical gold/silver For 10% off Gerald Celente's prescient Trends Journal, go to TrendsJournal.com and enter the code KNIGHTBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-david-knight-show--2653468/support.

(2:00) Well, Excuse ME! - The Corrupt Pardons of Both Biden and TrumpBiden (who tells us he never lies) lied about pardoning Hunter; pretends the DOJ is weaponized AGAINST him (but it's weaponized FOR him and for Hunter)Why did Biden stretch the pardon to an entire decade?  Why start with 2014?(15:54) Will Trump Renege on J6 Pardons?Trump's silence on J6 pardons — Hunter's pardon however, is GOOD NEWS for J6ersCowboys for Trump founder says "J6 was the greatest ENTRAPMENT in American history" — and it wasn't BidenWill Pam Bondi stop J6 pardons?Trump pardoned Jared Kushner's father, now appoints as Ambassador to FranceWhy was Jared's father's crimes described as "one of the most loathsome, disgusting crimes I prosecuted"?FOX & MAGA-Media gloss over the crimes, referring to them only as "witness tampering"Trump appoints another in-law (besides Kushner).  It's a Mafia Family(40:42) Trump's Con Man for CommerceTrump's Commerce Secretary — "Lucky" Lutnick and his history of Wall Street Scams like SPACs.  Why do the financial snakes always get Commerce Secretary under Trump?(58:58) LIVE comments - Pam Bondi, literal Drug War against cartels, SPACs, and more (1:11:59) What Happens When LOCAL Law Enforcement Goes Bad?The Sheriff who called in his deputies over a burger that wasn't done HIS wayProsecutor and police lab LIED and this man served DECADES in jail for a crime he did NOT commit(1:31:28) Hanging Chad — Conservatives Go After Trump's DEA Appointment One of the worst COVID tyrants and cheerleader for Vax & LGBT has been selected by Trump to head DEA.  Here's why Chad Chronister is the PERFECT pick (and why conservatives shouldn't be surprised) (58:58) LIVE comments - and our producers (1:56:51) NATO's War — And a NEW Arms RaceBiden loads up Ukraine with weaponsRussian warnings about how quickly their hypersonic missiles (for which there's NO defense) could strike Europe.  Now they show the vulnerability of US targets in Middle East AND AmericaPentagon says it will repurpose their ludicrous "Littoral Combat Ship" (the failed Zumwalt class) to fire hypersonic missiles (that they won't have for 3 or more years) because the original gun was too expensive to fire.  Why would THAT stop the Pentagon?France "removes ALL red lines" in war with RussiaNATO refuses to face reality — tells businesses to prepare for "wartime scenario"The new Arms Race(58:58) LIVE comments - munitions being emptied, Russia & Ukraine Shanghai men to fight, the meat grinder as the fight for "line of contact" escalates — and more producers (2:38:09) Why Being Grateful is Vital — Make America Grateful AgainTrump & Musk celebrate Thanksgiving at Mar-a-Lago — be grateful that you've NOT fallen into the snare that entraps themTo WHOM should we be grateful?Sales of Bibles are booming — why?Ontario town fined $10,000 for not worshipping LGBT during "Pride Month"Euthanasia — most Americans favor it, UK Parliament just passed itWhat does "pro-life" REALLY mean?If you would like to support the show and our family please consider subscribing monthly here: SubscribeStar https://www.subscribestar.com/the-david-knight-show Or you can send a donation throughMail: David Knight POB 994 Kodak, TN 37764Zelle: @DavidKnightShow@protonmail.comCash App at: $davidknightshowBTC to: bc1qkuec29hkuye4xse9unh7nptvu3y9qmv24vanh7 Money should have intrinsic value AND transactional privacy: Go to DavidKnight.gold for great deals on physical gold/silver For 10% off Gerald Celente's prescient Trends Journal, go to TrendsJournal.com and enter the code KNIGHTBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-real-david-knight-show--5282736/support.

In this episode of 'Just Ask the Press', host Brian Karem, along with national security expert Mark Zaid and editor John T. Bennett, delve into the week's significant political news. They discuss the controversial nomination of Kash Patel as FBI Director, exploring his background and the implications for the rule of law. The conversation then shifts to Charles Kushner's appointment as ambassador to France, highlighting his criminal past and the political motivations behind his nomination. The episode emphasizes the potential impact on the media and law enforcement under the new administration. In this conversation, the speakers discuss the implications of the upcoming inauguration, focusing on the potential retaliation against whistleblowers and the legal preparations being made. They also delve into Elon Musk's controversial comments regarding treason and the broader political climate, highlighting the desensitization of the public to political turmoil and the potential consequences of this shift in perception. Follow us on Twitter: https://twitter.com/JATQPodcastIntragram: https://www.instagram.com/jatqpodcastYoutube:https://www.youtube.com/channel/UCET7k2_Y9P9Fz0MZRARGqVwThis Show is Available Ad-Free And Early For Patreon supporters here:https://www.patreon.com/justaskthequestionpodcastPurchase Brian's book "Free The Press" 

President-elect Donald Trump announces Charles Kushner, who Trump pardoned during his first term, to serve as US Ambassador to France and conspiracy theorist Kash Patel to lead the FBI. Anthony Davis reports. Join this channel for exclusive access and bonus content: https://www.youtube.com/channel/UCkbwLFZhawBqK2b9gW08z3g/join Five Minute News with Anthony Davis is an Evergreen Podcast, covering politics, inequality, health and climate - delivering independent, unbiased and essential news for the US and across the world. Visit us online at http://www.fiveminute.news Follow us on Twitter http://twitter.com/fiveminnews Follow us on Instagram http://instagram.com/fiveminnews Support us on Patreon http://www.patreon.com/fiveminutenews You can subscribe to Five Minute News with your preferred podcast app, ask your smart speaker, or enable Five Minute News as your Amazon Alexa Flash Briefing skill. Please subscribe HERE https://www.youtube.com/channel/UCkbwLFZhawBqK2b9gW08z3g?sub_confirmation=1 CONTENT DISCLAIMER The views and opinions expressed on this channel are those of the guests and authors and do not necessarily reflect the official policy or position of Anthony Davis or Five Minute News LLC. Any content provided by our guests or authors are of their opinion and are not intended to malign any religion, ethnic group, club, organization, company, individual or anyone or anything. Learn more about your ad choices. Visit megaphone.fm/adchoices

The incoming Trump administration has just named its White House chief of staff and more appointments will be coming soon. WSJ's Andrew Restuccia on who is in the running and how this transition could be different from 2016. Further Reading: -The Scramble Is On to Fill Out Trump's Cabinet   -Lutnick Consults With Musk, Kushner, Wall Street in Rush to Staff Trump White House   -Meet the Wall Street Bigwig Who Has Become Trump's Headhunter in Chief   Further Listening: -Red, White and Who? Why Trump Won and Where Democrats Go Next  -What a Republican Congress Could Mean for Trump  Learn more about your ad choices. Visit megaphone.fm/adchoices

Oct 26, 2020Flynn's lawyers have until midnight Monday to declare that none of their other documents have been falsified, two Democratic House Committee Chairs verify that Pompeo is under investigation for violations of the Hatch Act, how the Wall Street Journal killed the Russian disinformation attempt by Bannon and Trump, Kushner tells Fox News some racist stuff, how the arrest of one of the Boogaloo Bois shatters Trump's “law & order” facade, one of Trump's impeachment lawyers was involved with the Hunter Biden email operation, Senate candidate Abby Broyles joins us for the Flip it Blue segment, plus Dana Goldberg (@DGComedy) joins AG for Hot Notes and the Good News.Follow our guests on twitter:Frank Figliuzzi (@FrankFigliuzzi1) Check out other MSW Media podcastshttps://mswmedia.com/shows/Subscribe for free to MuellerSheWrote on Substackhttps://muellershewrote.substack.comFollow AG and Dana on Social MediaDr. Allison Gill https://muellershewrote.substack.comhttps://twitter.com/MuellerSheWrotehttps://www.threads.net/@muellershewrotehttps://www.tiktok.com/@muellershewrotehttps://instagram.com/muellershewroteDana Goldberghttps://twitter.com/DGComedyhttps://www.instagram.com/dgcomedyhttps://www.facebook.com/dgcomedyhttps://danagoldberg.comHave some good news; a confession; or a correction to share?Good News & Confessions - The Daily Beanshttps://www.dailybeanspod.com/confessional/ Listener Survey:http://survey.podtrac.com/start-survey.aspx?pubid=BffJOlI7qQcF&ver=shortFollow the Podcast on Apple:The Daily Beans on Apple PodcastsWant to support the show and get it ad-free and early?Supercasthttps://dailybeans.supercast.com/Patreon https://patreon.com/thedailybeansOr subscribe on Apple Podcasts with our affiliate linkThe Daily Beans on Apple Podcasts

This week: big losses in court for Mark Meadows, Jim Jordan, the Georgia fraudulent electors, Jeffrey Clark, the State of Florida, and Rudy Giuliani; plus Congressional Democrats send a letter to the DoJ urging Merrick Garland to appoint a special counsel to investigate Kushner for possible FARA violations.  Allison Gillhttps://muellershewrote.substack.com/https://twitter.com/MuellerSheWrotePete Strzokhttps://twitter.com/petestrzokThe Podcasthttps://twitter.com/aisle45podWant to support this podcast and get it ad-free and early?Go to: https://www.patreon.com/aisle45podTell us about yourself and what you like about the show - http://survey.podtrac.com/start-survey.aspx?pubid=BffJOlI7qQcF&ver=short

Congress has agreed on a temporary spending bill to fund the federal government through Dec. 20. The House GOP’s hotly debated SAVE Act didn’t make the final cut. We’ll get into what did make it into the bill beyond bare-bones funding measures. And, a wave of homeowners are looking to refinance their mortgages as borrowing costs ease. Plus, we’ll cry happy tears over a “Homeward Bound” story come to life. Here’s everything we talked about today: “Kushner's Fund Has Reaped Millions in Fees, but So Far Returned No Profits” from The New York Times “US Mortgage Rates Fall Again, Triggering Big Wave of Refinancing” from Bloomberg “The final countdown” from Punchbowl News “Shippers scramble for workarounds ahead of looming US East Coast port strike” from Reuters “Cat Missing in Yellowstone Returns Home to California After an 800-Mile Trek” from The New York Times Tweet from Jacqui Heinrich about President Biden’s hot mic moment on “The View” Got any questions about inflation or interest rates? Send ’em to makemesmart@marketplace.org or leave us a voicemail at 508-U-B-SMART.

Congress has agreed on a temporary spending bill to fund the federal government through Dec. 20. The House GOP’s hotly debated SAVE Act didn’t make the final cut. We’ll get into what did make it into the bill beyond bare-bones funding measures. And, a wave of homeowners are looking to refinance their mortgages as borrowing costs ease. Plus, we’ll cry happy tears over a “Homeward Bound” story come to life. Here’s everything we talked about today: “Kushner's Fund Has Reaped Millions in Fees, but So Far Returned No Profits” from The New York Times “US Mortgage Rates Fall Again, Triggering Big Wave of Refinancing” from Bloomberg “The final countdown” from Punchbowl News “Shippers scramble for workarounds ahead of looming US East Coast port strike” from Reuters “Cat Missing in Yellowstone Returns Home to California After an 800-Mile Trek” from The New York Times Tweet from Jacqui Heinrich about President Biden’s hot mic moment on “The View” Got any questions about inflation or interest rates? Send ’em to makemesmart@marketplace.org or leave us a voicemail at 508-U-B-SMART.